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Abstract 
Keywords: Endophytes, Xylaria, fungi, secondary metabolites, NMR, structure 
  elucidation.      
This thesis describes the isolation and structure elucidation of secondary metabolites 
formed in static culture from a number of endophytic Xylariaceous fungi. Four Xylaria 
endophytes isolated from a palm tree in Thailand were surface cultured on an aqueous 
malt extract-glucose medium. They all produced cytochalasin D, coriloxin, (S)-mellein 
and (3R,4R)-4-hydroxymellein as the main secondary metabolites suggesting that the 
four endophytes could be the same species. The endophytic fungus A116 produced 
cytochalasin D as the main secondary metabolite.  Another non-endophytic fungus 
B315, produced cytochalasin D, (R)-mellein, a mixture of two isomers of 4-
hydroxymellein and phloroglucinol. X.62, an endophytic fungus, produced 19,20-
epoxycytochalasin C from the mycelium as the main secondary metabolite. The fungus 
Engleromyces sinensis produced engleromycin acetate as the main secondary 
metabolite. Fungus X. polymorpha produced (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’-
methylphenyl)-2-methoxybut-3-enoic acid. 
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Glossary  
°C   Degrees Celsius 
1D   One Dimensional 
2D   Two Dimensional 
[α]   Specific rotatory power 
δ  NMR chemical shift [ppm] 
ν  Wave number [cm-1] 
br   Broad 
c   Concentration [g/100 mL] 
cm   10
-2
 metre 
COSY   Correlated Spectroscopy 
d   Doublet 
DEPT   Distortionless Enhancement by Polarisation Transfer 
e.g.   Example given 
ES  Electrospray 
g   Gram 
HMBC  Hetero nuclear Multiple Bond Correlation 
HMQC  Hetero nuclear Multiple Quantum Coherence 
Hz   Hertz 
IR   Infrared 
J   Spin-spin coupling constant [Hz] 
L   Litre 
Lit  Literature 
m   Multiplet (in connection with NMR data) 
MeOH  Methanol 
MHz   Megahertz 
mp   Melting point 
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MS   Mass Spectrometry 
m/z  Molecular Ion 
NMR   Nuclear Magnetic Resonance 
PLC  Preparative Layer Chromatography  
ppm   parts per million 
q   Quartet 
s   Singlet 
sp.   Species 
t   Triplet 
TLC   Thin Layer Chromatography 
UV   Ultra Violet 
XRD  X-ray diffraction 
Rf  values refere to migration relative to the solvent front 
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Anamorph  the asexual reproductive manifestation of a fungus. 
Ascospore  a spore born in asci. 
Conidia   unicellular asexual reproductive spore produced externally. 
Conidiogenesis  the process of conidia formation. 
Holoblastic   the process of undergoing complete segregation. 
Telemorph   the sexual manifestation of a fungus. 
Genus    a taxonomic category that includes a number of species. 
Stroma  mass of fungal tissue within which or from which perithecia are 
form. 
Chemotaxonomy the classification & identification of fungi based on profiles of 
secondary metabolites. 
Mycelium collective term for hyphae; the vegetative thallus of a fungus 
excluding organs of sporulation. 
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Chapter 1   Introduction 
1.1 The Family Xylariaceae 
The Xylariaceae is a family of fungi belonging to the Ascomycota which traditionally 
has been divided into three main subclasses, Plectomycetes, Discomycetes and 
Pyrenomycetes.  The Xylariaceae belongs to the Pyrenomycetes subclass.  This family 
comprises of at least 40 genera
1-4
, but nearly 70 genera have now been listed
5
.  Although 
Xylariaceous fungi occupy a wide range of habitats, the majority are wood inhabitants
6
.  
These saprophytic fungi can be found on decayed wood, litter, fruits, seeds, dung and 
leaves and on insects
7, 8
.  
Many studies have revealed that members of Xylariaceae occur as endophytes
8-10
; a 
fungal microorganism, which spends the whole or part of its life cycle colonizing inter-
and/or intra-cellularly inside the healthy tissues of the host plant, typically causing no 
apparent symptoms of diseases
10
.  Studies have  shown that endophytes are a promising 
source of novel natural metabolites, which exhibit a variety of biological activities
11
.  
Such metabolites have potential use as pharmaceuticals.   
Over the past 25 years, the Xylariaceae have received considerable attention and as a 
result there is now a clear understanding of its constituent genera. In 1979 using 
morphological data, Rogers
12
 proposed a central core of closely related genera of family 
Xylariaceae comprising: Xylaria, Hypoxylon, Rosellinia, Poronia, Hypocopra, Daldinia, 
Camillea, Penzigia, Nummularia  and Kretzschmaria. In 1995 Whalley and Edwards
13
 
accepted the concept of core genera as proposed by Rogers.  In recent years Whalley
6
 
proposed a scheme illustrating the relationships between these genera. In this scheme he 
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related Xylaria to Hypoxylon and Nummularia.  He thought that Poronia is more related 
to Xylaria, whereas Rosellinia is closely related to Nemania. 
The taxonomic classification of fungi species has been attempted in different ways. This 
includes use of: 
- mycological data14, 15 
- chemical data6, 16 
- DNA profiling6, 17  
1.2 The Genus Xylaria 
Xylaria is a complex and the oldest known genus of the family Xylariaceae.  Xylaria 
species have a wide geographical distribution throughout the tropics, subtropics and 
temperate regions and more than 500 species are believed to belong to this genus
18
. 
Xylaria species are considered as saprophytes or weak parasites
19
.  Other Xylariaceaous 
species are pathogens  such as Entoleuca (Hypoxylon  mammata), which is a well known 
cause of canker disease
6
. 
In spite of the fact that Xylaria are widely available, their classification is often 
confused.  This is due to their variation in shape, colour, and size and even in form of the 
stroma depending on their level of maturity, host and environment.  Stromatal 
morphology has been the basis of classification of the Xylaria species by early 
researchers
20, 21
.  Rogers
22, 23
 Table 1, divided the Xylaria into four sections based on the 
place of their anamorph in their life cycle and the morphological structure of their 
conidiogenous and stromata (telemorph).  Although Rogers’s classification is more 
reliable, it is incomplete, and many gaps need to be filled because not all the species 
have been cultured and few Xylaria species have anamorphic data.  At the present there 
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is no stable reliable taxonomic system for Xylaria sub-genera. The use of 
chemotaxonomy could help to highlight the relations between the different species
24
. 
Table 1 Sub-division of Xylaria genera according to Rogers
22, 23
 
Section Characteristic features 
1 Conidia produced from palisade of conidiogenous cells over active 
young telemorphic stromata or at least not limited to specialised 
appendages, conidiogenesis holoblastic. Conidia produced in more or 
less sympodial sequence, seeding individually and passively. This 
section contains 5 groups: Xylaria polymorpha, X. hypoxylon, X. 
multiplex, X. pyramidata and X. pedunculata. 
2 
Conidia produced on special and localised peg or hairy-shaped 
appendages on young telemorphic stromata, conidia apparently seeding 
individually and passively. This section is represented by the X. comosa 
group. 
3 
Conidia produced on special anamorphic stromata or conidiomata 
which usually produced earlier in the year than telemorphic stromata. 
Telemorphic stromata never bear conidia, conidiogenesis holoblastic. 
Conidia produced in more or less sympodial sequence, seeding 
individually and passively, e.g. X. cubensis. 
4 
Conidia produced on young telemorphic stromata. Conidiogenesis 
apparently holoblastic. Conidia produced in tandem, discharging 
forcibly.  This section is represented by X. furcata. 
  
                             
Chapter 1  
                                                                                                                      
4 
 
1.3 Secondary metabolites from Xylariaceous fungi 
A fungal secondary metabolite is a chemical compound produced by a limited number of 
species in a genus. The chemical profile can be used as a taxonomic tool in the 
classification and identification of filamentous fungi and a big advantage of filamentous 
Ascomycetes is that they can be grown under standardised and controlled laboratory 
conditions.  A satisfactory production of secondary metabolites depends on the medium 
the fungi are cultured on.  The more complex a medium is the more chemical diversity 
the fungi will display
17
.  For comparative purposes, fungal cultures scheduled for 
chemotaxonomic analysis must always be grown on the same medium, incubated at the 
same temperature, and extracted in the same way, to ensure the differences are due to 
fungal diversity and not growth conditions. 
It is not unusual that different fungal species have one or more secondary metabolites in 
common. Cytochalasin D is one such metabolite.  It is produced by several fungal 
species
25-27
.  Secondary metabolites that have been isolated from various Xylaria species 
within the family Xylariaceae are presented in Table 2. 
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Table 2 Secondary metabolites from Xylaria species 
No Compound structure Xylaria species 
1 
HN
O
OHO
OAc
CH2
OH
HH
 
Cytochalasin D 
X. cubensis
28
  
X. hypoxylon
25
 
2 
HN
O
OHO
OAc
OH
H H
 
Cytochalasin C 
X. hypoxylon
25
 
3 
HN
O
OHO
OAc
O
H H
 
Cytochalasin Q 
X. obovata
29
  
X. hypoxylon
30
 
4 
 
 
HN
O
OHO
OAc
H
O
HO
 
Cytochalasin R 
X. hypoxylon
30
 
5 
 
O
O
OH
O
CHO
OH
 
Xylaral  
X. polymorpha
27
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6 
    
HN
O
OH
H
O
OH
OAc
H
O
 
19,20-epoxycytochalasin C 
X. obovata
29
  
X. hypoxylon
30
 
7 
HN
O
H
O
OH
OH
O
O
H
 
19,20-epoxycytochalasin Q 
X. hypoxylon
30
 
8 
 
 
 
 
CH C
COOHCOOH
H3C
CH[CH2]4CH3
 
2-Hexylidene-3-methylsuccinic acid 
X. polymorpha
31
 
X. hypoxylon
31
 
X. longipes
32
 
X. myosurus
33
 
9 
 
H3C
O
CH3
OH
OH
OH
OCH3
O
 
Globoscinic acid 
X. globosa
34
 
 
X. obovata
34
 
10 
   
O
O
O
O
 
Longianone  
X. longiana
33
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11 
  
O
OO
 
S-8-O-methylmellein 
X. species
35
 
12 O
OCH3H3C
O
H H
HHO  
Coriloxin  
X. species
35, 36
 
X. obovata
34
 
X. badia
37
 
13 
 
O
OOH  
Mellein 
(S) isomer: 
X. grammica
35, 38-41
 
(R) isomer: 
X. longiana
33
 
X. badia
37
 
X. species
35
 
14 
 O
O
H
H H
O-
O
 
Xylaric acid 
X. species
42
 
15 
O
OOH
OHH
 
4-Hydroxymellein 
X. grammica
35
 
X. longiana
18
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16 
O
COOH
OH O  
5-Carboxymellein 
X. species
35
 
X. myosurus
33
 
17 
O
OH O
H3CO
HO
 
8-Hydroxy-7-hydroxymethyl-6-methoxy-3-
methylisocoumarin 
X. species
35
 
18 
O
OH O
H3CO
OHC
 
7-Formyl-8-hydroxy-6-methoxy-3-
methylisocoumarin 
X. species
35
 
19 
O
OOH
H3CO
 
3,7-Dimethyl-8-hydroxy-6-methoxyisocoumarin 
X. species
35
 
20 
 
 
 
O
O
OH
OH
HOOC
 
4,8-Dihydroxy-1-methyl-3-oxo-isochroman-7-
carboxylic acid 
X. species
35
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1.4 Endophytes 
Endophytes (Gr. endo, within; phyton, plant) the term was first introduced by de Bary in 
1866 and has been deeply embedded in the literature ever since
43, 44
.  Carroll
45
 in 1988 
re-defined endophytes as fungi that exist within leaves and stems of healthy plants.  In 
1991, Petrini
46, improved Carroll’s definition stating that endophytes are organisms, that 
colonize internal plant tissues at least sometime in their life without causing apparent 
disease symptoms to the host. 
An endophyte is a bacterial or fungal microorganism, which spends the whole or part of 
its life cycle colonizing inter-cellularly inside the healthy tissues of the host plant 
without causing any immediate, overt negative effects
10
.  The most frequently isolated 
endophytes are fungi
47
.  Examination of plant material can lead to the discovery of 
endophytic fungi and bacteria.  The fungi isolated are often host specific
48
, so it is 
possible, that of the nearly 300,000 plant species that exist on the earth, each individual 
plant could be host to one or more endophytes
10, 11
. The number of endophytic species 
potentially associated with plants can reach several hundred
49
.  Furthermore, it has been 
reported, that endophytes are found in marine algae
50
, mosses and ferns
51, 52
.  
The environmental conditions under which the host is growing influence the endophyte 
diversity, and the endophyte profile may be more diversified in tropical areas
10
.  
Researchers recently noted that endophytes from tropical regions produced significantly 
more bioactive secondary metabolites than those from temperate parts of the world
53, 54
. 
The question of how microbial endophytes get into their host plants is still not clear. 
Fungal endophytes can gain access through the roots, but more are believed to enter 
through wounds in aerial parts of the plant or via stomata and bacterial endophytes are 
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not thought to invade plant tissue directly; instead, they tend to enter the plant through 
natural openings or wounds
55
. 
1.5 Endophytes and their host relationship 
Endophyte-infected plants often grow faster than non-infected ones.  This effect is due to 
the endophyte’s production of phytohormones and other plant growth-promotion 
substances
10
.  Endophytes may also enhance the hosts uptake of nutritional elements 
such as nitrogen
56
 and phosphorus
57-59
.  Additionally, some endophytes are able to 
enhance the  host plant tolerance to environmental stresses
10
, provide protection against 
nematodes
60, 61
 and insect herbivores
62, 63
 as well as bacteria and fungal pathogens
64, 65
. 
1.6 Natural products and drug discovery 
There is an increase in the number of people in the world having health problems caused 
by different diseases such as cancer, heart disease, drug–resistant bacteria and parasite 
infections.  An intensive search for  new and  more effective agents to treat these 
diseases is under way and fungi, particularly endophytes, are often a novel source of 
potentially useful medicinal compounds
66
.  
Treatments are needed for epidemic human diseases such as AIDS and other severe 
acute respiratory syndromes. Furthermore, the development of resistance to infectious 
microorganisms
67
 (e.g. Staphylococcus, Mycobacterium and Streptococcus), life 
threatening viruses and the recurring problems with diseases in persons with organ 
transplants. In addition, the world’s arsenal is not large for the treatment of parasitic 
protozoan infections, e.g. malaria, leishmaniasis and filariasis, which probably claim 
more lives each year than any other group of infectious agents, emphasizes the strong 
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need for new antibiotics
47
, chemotherapeutic agents and agrochemicals that are highly 
effective, possess low toxicity with less harmful effects on the environment. Novel 
natural products and the organisms that make them, offer opportunities for innovation in 
drug and agrochemical discovery
2
. 
It appears that an enormous, untapped source of microbial diversity is represented by the 
microbial endophytes, which produce various antimicrobial agents. The forests of the 
world are sources of these microbial endophytes (fungi and bacteria). There are 
numerous compounds of fungal metabolites, which are derived from various fungi of 
beneficial use in the modern medicine, agriculture and industry.  
Cyclosporin
66
, is a powerful immunosuppressant used in immunocompromised patients. 
Other fungi produce alkaloids
66
 that are used in the treatment of migraine. 
Griseofulvin
68
, is a metabolic product of many Penicillium species. It is widely used as 
an antifungal drug against dermatophytes. Cytochalasins
25
 are fungal metabolites with a 
novel mechanism of action on mammalian cells. Many studies have shown that 
cytochalasins have potential for clinical use as anticancer agents
69
.  In conclusion, it 
should be stated that only a few examples of fungi uses have been mentioned. One can 
say that more investigations on fungi need to be done. 
1.7 Natural products from endophytic fungi 
The secondary metabolites isolated from fungal endophytes have different biosynthetic 
pathways. They belong to different structural categories: isocoumarines, quinones, 
alkaloids, and phenols, etc. 
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1.7.1 Isocoumarin derivatives 
(R)-Mellein (1), an isocoumarin isolated from Pezicula sp.
70
, is a powerful fungicidal, 
herbicidal. Gamahorin (2) is an isocoumarin obtained from stromata of E. typhina on P. 
pratense
71
. 
 
O
OH
OOHOH  
(1) (2) 
1.7.2 Quinones 
Altersolanol A (3), is a highly hydroxylated quinone, found in phytopathogenic 
Alternaria cultures, was re-isolated from an endophytic  Phoma sp. and found to be an 
antibacterial agent
72
. 
OHO
OOH
H3CO
OH
OH
OH  
(3) 
1.7.3 Alkaloids 
Alkaloids are quite common secondary metabolites from endophytes, and some of them 
show antimicrobial activity.  Amines and amides were isolated from Acremonium 
endophytes which was later re-classified as the genus Neotyphodium
48
. 
O
OOH
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Peramine (4), a pyrrolopyrazine alkaloid, was extracted from Neotyphodium 
coenophialum, and from E. typhina
73
.  This secondary metabolite showed toxicity to 
insects with no harmful effect on mammals
74, 75
. 
N
N
O
N
H
NH2
NH
 
(4) 
Another group of compounds that possess antitumor and antibiotic activities are 
cytochalasins. Cytochalasins are alkaloids which are commonly produced by endophytic 
fungi such as Xylaria, Phoma, Hypoxylon and Chalara genera. 
Furthermore, three new cytotoxic cytochalasins (5-7), together with the known 
metabolite cytochalasin E (8) were characterised from a Rhinocladiella
76
 sp. commonly 
found as a saprophyte on dead tree limbs of a medicinal plant, Tripterygium wilfordii. 
  
(5) (6) 
 
 
(7) (8) 
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1.7.4 Phenols 
Phenol and phenolic acids have often been isolated from endophyte cultures originating 
from a variety of host plants
77
. 
Pestalachloride A-C (9-11), three new chlorinated benzophenone derivatives, have been 
isolated from cultures of an endophytic fungus Pestalotiopsis adusta. Pestachlorides A 
and B displayed significant antifungal activities against three plant pathogens
78
. 
  
 
(9) (10) (11) 
Endophytic fungi can produce compounds with antimicrobial as well as antioxidant 
activity. Pestacin (12) and isopestacin (13), have been isolated from culture media of P. 
microspora, an endophyte isolated from a plant called Terminalia morobensis growing 
in the Sepik river drainage of Papua New Guinea
79, 80
.  Both pestacin (12) and 
isopestacin (13) display antimicrobial as well as antioxidant activity
79, 80
. 
O
H3C
OH
HO OH
 
O
O
HO
OH
OH
H3C
 
(12) (13) 
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1.7.5 Others 
Chaetomellic acids A (14) and B  (15) isolated from the culture of an endophytic 
Chaetomella acutisea were found to be specific inhibitors of farnesylprotein transferase 
(FPTase)
81
. 
CO2H
CO2HH3C
 
CO2H
CO2HH3C
 
(14) (15) 
Ambuic acid  (16), a highly functionalised cyclohexenone isolated from P. microspora, 
possesses antifungal activity
82
. 
COOH
O
OHOH
O
 
(16) 
1.8 The aims of the project 
This project is designed to achieve the following objectives: 
- Create secondary metabolite profiles of the studied Xylariaceous and endophytic 
fungi. 
- Search for novel and bioactive secondary metabolites produced by Xylariaceous 
and endophytic fungi. 
- Apply NMR and other spectroscopic techniques to elucidate the structure of 
isolated secondary metabolites.
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Chapter 2 Secondary metabolites from endophytic fungi 
2.1 Endophytic fungi profile 
Five endophytic fungi were collected from the palm tree leaves Borassodendron 
machadonis from Trad Province in Southern Thailand Figure 1. 
 
Figure 1 Borassodendron machadonis palm tree 
The fungi were provided by Prof.  A-J-S Whalley, Liverpool John Moores University, as 
cultures in Petri dishes.  The five endophytes, coded   B231b, B127R, B115, B338 and 
A116, were static sub-cultured for two weeks in ten conical flasks, two for each fungus.  
Each conical flask contained an aqueous malt extract medium.  This Chapter describes 
the examination of cultures of the fungi for their metabolites.  Fungi B231b and B127R 
grew with a broad white mycelium, whereas fungus B115 developed light brown fruiting 
bodies, which grew 1.0-1.5 cm high with a base diameter of 0.5 mm on the white upper 
surface of the mycelium.  Fungus A116 developed black cylindrical shaped-stromata 
with a black base on a white mycelium, whilst fungus B338 produced a black mycelium 
Figure 2. 
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Fungus B231b Fungus B127R 
  
Fungus B115 Fungus A116 
 
Fungus B338 
 
Figure 2 Endophytic fungi after 10 days 
Each different endophyte was then transferred into 10 Thompson bottles (2 L) and 
allowed to grow on a sterile aqueous malt extract-glucose mixture for 8 weeks. Master 
cultures of each of these endophytes were made for future reference.  The matured 
cultures were harvested and the mycelia removed by filtration through a muslin cloth.  
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The respective aqueous filtrates were extracted in batches with ethyl acetate in a 
separating funnel (5 L) and the combined ethyl acetate extracts for each fungus were 
dried over anhydrous sodium sulphate.  Removal of the solvent by rotary evaporation 
gave the crude extracts details of which are summarised in Table 3.   
Table 3 Summary of properties of endophytes crude extracts 
Fungus Crude Yields Description 
 
B127R 
 
 
10.1 g 
 
Brown gum 
 
B338 
 
4.6 g 
 
 
Gummy brown liquid 
 
B231b 
 
 
6.2 g 
 
Brown gum 
 
B115 
 
 
2.7 g 
 
Brown gum 
 
A116 
 
0.58 g 
 
Yellow crystals 
 
Fungus A116 gave yellowish crystals (0.58 g), which were triturated with acetone and 
recrystallised from methanol to give pure white hairy needles (12 mg) of cytochalasin D.  
TLC studies of the four crude extracts indicated that the endophytes (B127R, B338, 
B231b and B115) all produced the same metabolites. 
2.2 Isolation of secondary metabolites from fungus B127R medium 
2.2.1  Isolation of Cytochalasin D  
The crude extract of B127R (10.1 g) was taken up into ethyl acetate (20 ml) producing a 
thick creamy solution.  The solution set aside for 24 h.  A fine white solid (106 mg) 
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precipitated from the solution.  The solid was filtered off and recrystallised from 
methanol to give white needles (79 mg), mp 230-232 °C, ES [M+H]
+
  m/z 508, [α]  -
12.5º (c 1, in dioxane).  This compound showed an opaque spot when treated with 
diazotised p-nitroaniline spray reagent, at Rf 0.24 in solvent system; toluene, ethyl 
acetate and acetic acid (50:49:1) on TLC.  The IRATR νmax cm
-1 
spectrum of this 
compound showed signals at: 3419, 1741 and 1692, which could indicate the presence of 
the following functional groups: a hydroxyl, a carbonyl ester and an amide. 
1
H NMR spectrum (C5D5N, Figure 5) was complex showing several sets of peaks across 
the region δ 0.5 to δ 9.5.  The 13C NMR and DEPT-135 spectra (C5D5N, Figure 6&7) 
showed 28 carbon signals.  The signals at δc 128.79 and 129.89 are double the height of 
other peaks signifying that these signals are each probably due to two carbon atoms 
giving a total of 30 carbons. The DEPT-135 spectrum showed four methyl signals at δc 
13.59, 19.34, 20.51 and 24.60, three methylene signals at δc 38.54, 45.49, and 112.16 
and seven quaternary signals at δc 210.86, 175.09, 170.45, 151.61, 138.43, 78.38 and 
53.98 and seven methine signals in the olefinic aromatic/region between δc 126-134 and 
nine further methine carbon signals in the region of δc 13-80. 
The spectral and physical data of this compound suggested it was a cytochalasin, which 
have been previously reported as secondary metabolites from Xylariaceaous fungi
28, 35
.  
Comparison of 
1
H and 
13
C NMR data of this compound with the reported data
25
 for a 
series of cytochalasins revealed that this compound was cytochalasin D (C30H37NO6).  
The proton signal observed at δH 9.08 and the methylene signal in the DEPT spectrum at 
δC 112.16 are particularly indicative of cytochalasin D Figure 3.  
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The 
1
H NMR, 
13
C NMR and DEPT-135 assignments for cytochalasin D are presented in 
Table 5.  2D NMR techniques (
1
H-
1
H COSY, HMQC and HMBC experiments) were 
used to determine connectivities in addition to the 
1
H and 
13
C NMR data. 
'5
'4
3
'
2'
1'
'
6
HN
3
10
21
9
4 8
7
6
5
20
19
13
18
17
16
15
14
O
O
H H
OH
CH2
H3C
O
CH3
C O
CH3
OHH3C
2
1
25
24
23
11
12
22
 
Figure 3 Cytochalasin D 
 
1
H NMR spectrum (C5D5N, Figure 5) showed the presence of four methyl peaks in the δ 
0.76 to 2.41 region. The most deshielded signal is the methyl of the ester group C-25 at 
δH 2.41. The magnetically non-equivalent protons 15-Ha and 15-Hb gave multiplets at 
δH 1.90-1.93 and 2.58-2.63 respectively. The 4-H proton appeared at δH 2.42, whereas, 3-
H appeared as singlet at δH 3.54.  The 10-H protons are represented by a multiplet signal 
at δH 2.80-2.83.  The 7-H proton is seen at δH 4.40 and the hydroxyl proton at the same 
position appeared at δH 4.98 as a singlet, whilst the signals at δH 5.04 and 5.40 indicated 
possible alkene protons. The 13-H appeared as multiplet at δH 5.60-5.61, whilst 14-H 
gave a multiplet signal at δH 6.30-6.35.  The other macrocyclic double bond has a 
multiplet signal at δH 5.54-5.59 for 19-H and doublet of doublet at δH 6.83 for 20-H.  The 
21-H proton appeared as a singlet at δH 6.18.  The aromatic protons were grouped 
together at δH 7.20-7.35 and the compound specific N-H peak appeared downfield at δH 
9.08. 
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The chemical shift of the N-H proton of the lactam ring in cytochalasin compounds 
appears generally above δH 9.0, when pyridine-d5 is used as the NMR solvent.   It has 
been observed that the signal for this proton can be characteristic for cytochalasin
69
 
Table 4.  In cytochalasin D for instance, the N-H proton resonates at δH 9.08, which is 
the case for the isolated cytochalasin. 
Table 4 Characteristic physical data of some cytochalasins
25
 
Cytochalasin Amide δH in pyridine mp °C m/z 
C  9.38 260- 265 507 
D  9.13 267-270 507 
N  9.55 272 523 
O  9.25 258- 265 525 
P  9.10 169-173 525 
Q  9.45 145-147 507 
R  9.7 159-167 523 
 
The cytochalasins are a class of secondary metabolites produced during fungal growth, 
which exhibit unusual behaviour on animal cells.  The series of structurally related 
natural products of ever increasing number has grown steadily in size since they were 
first isolated in the 1960s
69
.  The cytochalasins are generally characterised as containing 
a highly substituted  perhydroisoindolone ring system which is fused to a macrocyclic 
ring of varying size (11-14 atoms in length and containing either carboxylic, lactonic or 
carbonate moieties), a typical example is cytochalasin C
83
 Figure 4. 
  
                                                                                                                          Chapter 2 
22 
 
HN
O
CH3
H3C OH
O
CH3
OAc
HH
H3C OH  
Figure 4  Cytochalasin C 
The first members of the series were discovered independently by two groups almost 
simultaneously;  Tamm and Rothweiler
83
 working at the University of  Basel,  
Switzerland, and Aldridge and Turner of  ICI in Cheshire, UK
84
. Since then it has been 
isolated by several other workers.  Edwards et al
25
  isolated this compound alongside 
other new cytochalasins N, O, Q, R and P from the fungus Hypoxylon terricola at the 
University of Bradford. 
The name cytochalasin (from the Greek – cytos, a cell and – chalasis, relaxation) was 
proposed for this class of compounds, which was being descriptive of the characteristic 
effects when cells were treated with these compounds
69
. 
The biological activity of the cytochalasins was first reported by Carter
69
 in the late 
1960s, when unusual effects were observed upon specific strain of mouse fibroblast, 
which were treated with cytochalasin containing solution.  It was discovered that 
cytochalasin B, at a concentration of 1µg/ml, prevented cytokinesis (cytoplasmic 
cleavage), whilst having no effect upon mitosis (nuclear division). Cytochalasin C and D 
were found to completely prevent cell cleavage at a dose as low as 0.05µg/ml. Under 
normal cellular conditions, mitosis occurs followed by the formation of a deep furrow in 
the cytoplasm, which cleaves to yield two identical cells.  With the addition of 
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cytochalasin B to the culture medium, the treated cells undergo nuclear division as 
normal, but the cytoplasmic furrow does not fully develop and subsequently recedes. As 
a consequence, cytokinesis does not take place and leads to the formation of bi-
nucleated cells.  Inhibition of cell motility was also observed at a concentration of 
0.5µg/ml, when the addition of cytochalasin B to the culture medium immobilised cells 
for extended period of time,  which was fully reversible with replacement of the old 
medium with fresh stock.
69
 Cytochalasin D is a major metabolite produced by 
endophytic fungi which could be a source of a commercial supply of this metabolite.
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Table 5  
1
H and 
13
C NMR assignments for cytochalasin D (C5D5N) 
No δH δC DEPT 
1  175.09 C 
2 9.08 (1H, s) NH  
3 3.54 (1H, s) 54.35 CH 
4 2.42 (1H, s) 50.07 CH 
5 3.00 (1H, s) 33.13 CH 
6  151.61 C 
7 4.40 (1H, d, J 10.3 Hz) 71.26 CH 
7-OH 4.98 (1H, s)   
8 3.35-3.39 (1H, m) 47.86 CH 
9  53.98 C 
10 2.80-2.83 (2H, m) 45.49 CH2 
11 0.76 (3H, d, J 6.7 Hz) 13.59 CH3 
12a 5.04 (1H, s) 112.16 CH2 
12b 5.40 (1H, s)   
13 5.60-5.61 (1H, m) 127.82 CH 
14 6.30-6.35 (1H, m) 132.75 CH 
15a 1.90-1.93 (1H, m) 38.54 CH2 
15b 2.58-2.63 (1H, m)   
16 2.66-2.70 (1H, m) 42.43 CH 
17  210.86 C 
18  78.38 C 
19 5.54-5.59 (1H, m) 132.18 CH 
20 6.83 (1H, dd, J 2.5, 13.3 Hz) 133.81 CH 
21 6.18 (1H, s) 77.98 CH 
22 0.97 (3H, d, J 6.5 Hz) 19.34 CH3 
23 1.49 (3H, s) 20.51 CH3 
24  170.45 C 
25 2.41 (3H, s) 24.60 CH3 
1’  138.43 C 
2’,6’ 7.20-7.35 (2H, m) 129.89 CH 
3’,5’ 7.20-7-35 (2H, m) 128.79 CH 
4’ 7.20-7.26 (1H, m) 126.79 CH 
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2.2.2 Isolation of Coriloxin  
After the isolation of cytochalasin D, the remaining filtrate was concentrated in 
vacuo to yield a brownish gummy liquid (5.0 g), which was triturated with acetone 
and set aside overnight. This afforded dark brown crystals, which were recrystallised 
twice from toluene to give optically active colourless needles (103 mg), mp 153-155, 
°C, ES [M+H]
+
  m/z  171, [α]   -98.4º (c 1, in EtOH), IRATR νmaxcm
-1
  3403, 1648 
and 1607 cm
-1
.  The strong peak at 3403 cm
-1
 suggests the presence of a hydroxyl 
group. Two bands at 1648 and 1607 cm
-1
 might be due to a conjugated carbonyl and 
a double bond.  The 
1
H NMR spectrum (CDCl3, Figure 11) showed only 6 sets of 
signals indicative of ten protons.  The signal at δH 5.23 is most likely a methine 
proton attached to an olefinic carbon.  A low field methine proton at δH 4.46 might be 
due to an attachment to an oxygen to the carbon bearing this proton.  The resonance 
position of the methoxy group at δH 3.73 suggests it is attached to an unsaturated 
carbon.  There is a singlet at δH 1.62 indicative of a methyl group, which could 
possibly be attached to a carbon directly attached to an oxygen atom.  The resonance 
peak at δH 2.68 is due to a hydroxyl proton which is indicated in the IR spectrum. 
The 
13
C NMR spectrum (CDCl3, Figure 12) showed eight carbon resonances.  A 
DEPT-135 spectrum showed these comprised two methyl signals at δC 19.02 and 
56.69, three methine signals at δc 60.65, 69.21 and 98.29 and three quaternary 
carbons at δc 59.55, 171.54 and 193.56.  The resonance peak at δc 193.56 is strongly 
indicative of a conjugated ketone, which is supported by an IR absorption at 1648 
cm
-1.  The signals at δc 56.69, 59.55, 60.65 and 69.21 suggested carbons adjacent to 
oxygen atoms. Excluding the carbonyl signal at δc 193.56, three oxygen atoms are 
left for four carbons, which suggests the presence of an epoxide group.  The physical 
and spectral data of this compound was compared with literature data
85
, which 
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revealed that this compound is coriloxin Figure 10.  A summary of 
1
H NMR, 
13
C 
NMR and DEPT- 135 data are listed in Table 6. 
6
5
4
3
2
H
H3C O
CH3
O
O
H
HHO  
Figure 10 Coriloxin 
 
Table 6 
1
H and 
13
C NMR data of coriloxin (CDCl3) 
No δC Multiplicity δH 
1 193.56 C  
2 98.29 CH 5.23 (1H, d,  J  1.7 Hz) 
3 171.54 C  
4 69.21 CH 4.46  (1H, d,  J  6.2 Hz) 
5 59.55 C  
6 60.65 CH 3.30  (1H, d,  J  1.7 Hz) 
7 19.02 CH3 1.62  (3H,  s) 
8 56.69 CH3 3.73  (3H,  s) 
* OH group OH 2.68  (1H, d,  J  6.2 Hz) 
 
Coriloxin is a known natural product. It was first isolated and identified from the 
culture medium of the fungus Coriolus vernicipes in Japan
85
.  It was also reported 
from unpolished rice fermented with a  Xylariaceous endophytic fungus
36
.  It shows 
antimicrobial activity against Staphylococcus aureus and Candida albicans with 
MIC values of 100 µg/ml and 200 µg/ml respectively
36
. Coriloxin has been isolated 
previously at University of Bradford from X. Obovata
86
,  X. Badia
37
,  Adeboya
86
 and 
other Xylaria species
87
. 
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2.2.3 Isolation of Mellein 
After removal of coriloxin the crude product had a dry weight of (3.3 g). Two 
portions (1 g each) of this brownish viscous liquid were chromatographed on two 
large thick layer plates (20 x 80 cm); (1.0 g) on each plate. The plates were 
developed in a tank containing a solvent system toluene, ethyl acetate, acetic acid 
(500:490:10).  After the plates developed, they were removed and air-dried and then 
strips (1.0 cm) at the edges were sprayed with diazotised p-nitroaniline spray reagent 
to detect the bands. 
(Band 1) (Rf 0.91) was scraped off and washed with ethyl acetate which was 
removed in vacuo to yield a yellow oil, which was triturated with n-hexane to give a 
powdery solid (7.5 mg) which was recrystallised from the same solvent to yield 
colourless plates (3 mg), mp 52-53 °C, ES [M+H]
 +
 m/z 179, [α]  +87º (c 1, in 
CHCl3), IRATR νmax cm
-1 
3187, 1662.  The IR absorptions suggested the presence of 
hydroxyl and carbonyl groups.  The compound had Rf 0.91 on a silica gel TLC plate 
eluted with toluene, ethyl acetate, acetic acid (50:49:1).  It showed a strong orange 
spot with diazotised p-nitroaniline; suggesting the compound possessed a phenolic 
group, but was not active with anisaldehyde spray reagent. 
The 
1
H NMR spectrum (CDCl3, Figure 17) had a strong singlet at δH 11.02 indicating 
the presence of a chelated OH.  Three signals were observed in the aromatic region 
(δH 6.5-8.5); two doublets at δH 6.67 (J 7.3 Hz) and 6.87 (J 8.4 Hz) coupled to a  
pseudo triplet at δH 7.39 (J 7.5 Hz). These signals indicated a tri-substituted ring.  
Also, three signals at δH 1.51 (3H, d, J 6.3 Hz), 2.91 (2H, d, J 7.0 Hz) and a multiplet 
signal in the region 4.70-4.73 (1H, m). The position of this methine proton indicates 
that it is attached to a C-O group. 
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In the 
13
C NMR spectrum (CDCl3, Figure 18) ten carbon signals comprise a methyl 
carbon at δc 20.88, a methylene carbon at δc 34.73, a methine at δc 76.21 and a 
carbonyl at δc 170.07. Six resonance positions are in the aromatic regions which 
occur at δc 108.41, 116.36, 118.00, 136.25, 139.50 and 162.31. The quaternary 
carbon at δc 170.07 is a typical of a carbonyl of a lactone.  The chelated OH occurs at 
δH 11.02 indicating that the OH is in the neighbourhood of the carbonyl group 
according to the low infrared-absorption at 1662 cm
-1
. The mass spectrum, 
1
H and 
13
C NMR suggested a molecular formula of C10H10O3. 
In the 
1
H-
1
H COSY spectrum (CDCl3, Figure 20) the doublet methyl proton at δH 
1.51, which correlates to δC  20.88 in the HMQC spectrum (CDCl3, Figure 21) 
showed coupling to a methine proton at δH  4.70-4.73, which correlates to δC  76.21 in 
the HMQC.  The down field carbon signal at δC 76.21 suggested an adjacent oxygen 
atom.  The methine proton at δH 4.70-4.73 also coupled to the methylene protons at 
δH 2.91 which showed a cross peak with δC 34.73 in the HMQC spectrum.  This give 
a partial structure X. 
O
CH3
H
HH
34.73
76.21
2.91 2.91
1.51
 
X 
The three protons in the aromatic region at δH 6.67, 6.87 and 7.39 suggested a 
phenolic ring.  Also, six aromatic carbons three of which are quaternary according to 
the DEPT-135 analysis, (CDCl3, Figure 19) suggesting a 1,-2,-3-trisubstituted 
benzene ring; partial structure Y. 
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                                                                     Y 
The singlet proton at δH 11.02 is a characteristic signal for a chelated–OH group. The 
carbon signal at δC 170.07 suggested an ester carbonyl carbon.  According to the low 
infrared absorption at 1662 cm
-1
 a chelated lactone system was likely. Combining the 
two structures gave the structure of mellein Figure 15. 
 
6
7
8
9
10
5
1
O
3
4
O
CH3
OH  
Figure 15 Structure of mellein 
The NMR assignments for the compound, which were established using 1D and 2D 
NMR spectral experiments, 
1
H, 
13
C, DEPT-135, 
1
H-
1
H COSY and HMQC 
experiments, are presented in Table 7. 
  
OH
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Table 7 
1
H and 
13
C NMR assignments of mellein (CDCl3) 
No δC δH 
1 170.07-C  
3 76.21-CH 4.70-4.73  (1H, m) 
4 34.73-CH2 2.91 (2H, d,  J  7.0 Hz) 
5 118.00-CH 6.87 (1H, d,  J  8.4 Hz) 
6 136.25-CH 7.39 (1H, t,  J  7.5 Hz) 
7 116.36-CH 6.67 (1H, d,  J  7.3 Hz) 
8 162.31-C  
9 108.41-C  
10 139.50-C  
11 20.88-CH3 1.51 (3H, d,  J  6.3 Hz) 
* OH group 11.02 (1H, s) 
 
Mellein is a common secondary metabolite from Xylaria fungi. It was first isolated in 
1933 from  Aspergillus melleus
39,88
.  It has also been  isolated in Bradford from 
different Xylaria fungi such as X. Longiana
33
,  X. Grammica
35
,  X. Badia
37
 and other 
species of Hypoxylon
89
.  It has also been found
39, 89
 that fungi which produced this 
metabolite can produce other derivatives such as 4-hydroxymellein, 5-
carboxymethylmellein and 8-O-methylmellein. 
 Mellein exists naturally in two enantiomer forms; the most common form R-(-)-
mellein where optical rotation [α]  -92.5º (c 1, in EtOH) was isolated from 
Lasiodiplodia theobromae
41
.  Islam et al reported
90
 the synthesis of R-(-)-mellein 
with optical rotation [α]  -102º (c 0.53, in CHCl3)
90
.  Dimitriadis et al  reported
91
 the 
stereospecific synthesis of both enantiomers of mellein, where the optical rotation of 
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S-(+)-mellein  is [α]   +88.6º (c 0.27, in MeOH)  and for R-(-)-mellein is [α]  -
101.3º (c .07, in CHCl3).  By comparing these optical rotations with that of the 
isolated mellein the later was confirmed as S-(+)-mellein Figure 16. 
O
OOH
CH3
H
 
O
OOH
CH3
H
 
S-Mellein R-Mellein 
Figure 16 S and R enantiomers of mellein 
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2.2.4 Isolation of cis-4-Hydroxymellein  
The next UV active band on the preparative TLC plate at Rf 0.71, that developed a 
strong orange colouration when sprayed with diazotised p-nitroaniline spray reagent; 
suggesting a phenolic compound, was recovered.  The recovered silica was washed 
with ethyl acetate to yield a yellow solution.  The solvent was removed in vacuo to 
produce yellowish needles, which were recrystallised from toluene to yield fine 
colourless prisms, (87 mg), mp 112-117 °C, ES [M+H]
+
 m/z 195, [α]  +48º (c 1, in 
MeOH), IRATR  νmaxcm
-1 
 3430,  3178, 2997,  1642 and 1615.  IR absorptions at 3430 
and 3178 cm
-1
 in the spectrum of this compound indicated the presence of two 
hydroxyl groups.  The absorption at 3178 cm
-1 
suggested a hydrogen bonded 
hydroxyl group, whilst the absorption at 3430 cm
-1 
indicated a non-hydrogen bonded 
OH. 
The 
1
H NMR spectrum (CDCl3, Figure 25) suggested a mellein type compound. The 
methylene signal of mellein at δH 2.91 is absent and has been replaced by an 
oxygenated methine proton at δH 4.68.  The proton spectrum showed a singlet at δH 
10.98 suggesting the presence of the chelated-hydroxyl group. Three peaks were 
observed in the aromatic region (δH 6.5-8.5); 6.90 (1H, d, J 7.3 Hz), 7.01 (1H, dd, J 
8.4, 0.9 Hz) and 7.50 (1H, t, J 7.3 Hz).  A methyl group at δH 1.57 (3H, d, J 6.6 Hz).  
A methine proton at δH 4.69 (1H, qd, J   6.6, 2.0 Hz) could be attached to an 
oxygenated carbon.  A 
1
H-
1
H COSY spectrum (CDCl3, Figure 28) showed coupling 
between the doublet of quartets of  δH 4.69 and the doublet methyl group at δH 1.57 
as well as the doublet methine proton at δH 2.04 (1H, d,  J  6.4 Hz), which would 
account for the OH group at the C-4.  The chelated-OH signal at δH 10.98 suggests 
that this group is in the neighbourhood to the quaternary carbon at δc 169.26 which is 
indicative for an ester carbonyl group. The IR spectrum shows a band at 1642 cm
-1
, 
                      Chapter 2 
47 
 
characteristic of a hydrogen bonded lactone system. The 
1
H-
1
H COSY spectrum 
indicated coupling between the aromatic protons.  The proton at δH  6.90 (1H, d, J 7.3 
Hz) and proton at δH 7.01 (1H, dd, J 8.4, 0.9 Hz) are coupled to a pseudo triplet  at δH  
7.50 (1H, t,  J  7.3 Hz);  indicative of a three proton spin- system.  In the 
13
C NMR 
spectrum (CDCl3, Figure 26) showed six aromatic carbons are detected at δc 162.25, 
140.58, 136.92, 118.71, 118.39 and 106.94, four of which are detected as quaternary 
carbons according to the DEPT-135 (CDCl3, Figure 27); suggesting the ring is tri-
substituted. The 
1
H NMR has also detected the possible coupling between the 
hydroxyl peak at δH 2.04 (OH, d, J 6.4 Hz) and the methine peak at δH 4.68 (1H, dd, J 
6.1, 1.8 Hz).  By combining the m/z of mellein to that of this compound, it is 16 units 
larger than that of mellein, indicating additional oxygen. The absence of a methylene 
signal in the carbon spectrum of this compound compared to that of mellein indicates 
this compound is substituted at C-4.  
The replacement of the methylene carbon in mellein with a down field carbon at δc 
78.27 suggested the substitution at C-4 to be a hydroxyl group, which means that this 
compound is 4-hydroxymellein Figure 22. Comparison of the 
1
H and 
13
C NMR data 
of this compound with literature data
92
 showed it to be cis-4-hydroxymellein
41, 92
 
(Figure 23; structures A and B). 
O
OOH
CH3
OHH
 
Figure 22 4-Hydroxymellein 
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It is possible to decide, if there is a cis or trans relationship between the protons at C-
3 and C-4 in 4-hydroxymellein, by determination the coupling constant between the 
two protons.  A coupling constant
93
 of 2 Hz is consistent with the cis form, whilst a 4 
Hz coupling constant is associated with the trans form. 
A spin decoupling NMR experiment was performed by irradiation of the methyl 
group protons at position C-11. This eliminated the coupling between the methyl 
group protons and the proton at position C-3.  The quartet of doublets signal at 4.69 
Hz collapsed leaving a doublet peak.  The J-coupling between the 3-H and 4-H was 
measured as 2.0 Hz.  On this basis, the cis-configuration was assigned.  
The NMR data of the compound were established by using 1D and 2D NMR spectral 
experiments; 
1
H,
13
C, COSY and HMQC.  The later revealed all H-C direct 
correlations and thus confirmed the assignment of all carbons with attached protons 
Table 8.  
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Table 8 
1
H and 
13
C assignments for 4-hydroxymellein (CDCl3) 
No δC δH 
1 169.26-C  
3 78.27-CH 4.69 (1H, qd, J  6.6, 2.0 Hz ) 
4 OH group 2.04 (1H, d, J  6.4 Hz) 
4 67.39-CH 4.68 (1H, dd, J  6.1, 1.8 Hz) 
5 118.71-CH 6.90 (1H, d, J  7.3 Hz) 
6 136.92-CH 7.50 (1H, t, J  7.3 Hz) 
7 118.39-CH 7.01 (1H, dd, J  8.4, 0.9 Hz) 
8 162.25-C  
9 106.94-C  
10 140.58-C  
11 16.15-CH3 1.57 (3H, d, J  6.6 Hz) 
* OH group 10.98 (1H, s) 
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The 4-hydroxymellein molecule can exist in four stereoisomeric forms due to the 
chiral centres at C-3 and C-4 Figure 23.  There are two cis-isomers (3S,4S)-4-
hydroxymellein (A), (3R,4R)-4-hydroxymellein (B), and the two trans-isomers 
(3S,4R)-4-hydroxymellein (C), and (3R,4S)-4-hydroxymellein (D). 
O
OH O
CH3
OHH
H
 
 
O
OH O
CH3
OHH
H
 
 
(3S,4S)-4-hydroxymellein (A) (3R,4R)-4-hydroxymellein (B) 
O
OH O
OHH
CH3
H
 
 
 
O
OH O
H
OHH
CH3
 
  
(3S,4R)-4-hydroxymellein (C) (3R,4S)-4-hydroxymellein (D) 
Figure 23 4-Hydroxymellein enantiomers 
The compound can exist as one of two cis-isomers Figure 23.  The relative 
stereochemistry of  the compound was determined by x-ray diffraction studies
94
.  The 
data showed the hydrogen atoms at C-4 and C-3 were in the axial and equatorial 
positions respectively, confirming not only that the compound is in the cis-form, but 
it also showed that the compound is in the (3R,4R) configuration Figure 24. 
  
                      Chapter 2 
51 
 
 
Figure 24 (3R,4R)-4-Hydroxymellein
94
 
4-Hydroxymellein of undetermined stereochemistry has been isolated previously 
from Aspergillus oniki
95
, Anisospora camptospora
41
 and Aspergillus ochraceus
40
.  
Cis-3S,4S-4-Hydroxymellein (A) in addition to mellein, has been isolated from the 
mycelium of Cercosspora taiwanensis
96
 grown on potato-agar.  3R,4R-4-
Hydroxymellein has also been found in cultures from Lasiodiplodia theobromae
41
, 
Septoria nodorum
97
 and Aspergillus melleus
39, 92
. 
3S,4R-4-Hydroxymellein (C) has been isolated previously at Bradford University 
from the fungus Xylaria grammica
35
.  3R,4S-4-Hydroxymellein (D) has been isolated 
from the medicinal plant Moringa oleifera
98
 and together with  the 3R,4R isomer 
from the fungus Septoria
38
.   
Cis-4-hydroxymellein has been tested for bioactivity
47, 99
.  It showed good activity 
against the alga Chlorella fusca and against the Gram positive Bacillus megaterium.  
It also showed antifungal activity against Microbotryum violaceum, which suggest 
that the endophytic fungus could protect the host by producing metabolites, which 
may be toxic or even lethal to phytopathogens and highlights the potential of 
endophytic fungi in producing bioactive metabolites
47, 99
. 
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(3R,4R)-4-Hydroxymellein and (3R,4S)-4-hydroxymellein were both isolated from 
Sephaeropsis sapinea
100
.  They showed a synergistic activity, when assayed for 
phytotoxic and antifungal activities on host and non-host plants
100
. 
2.3 Isolation of cytochalasin D from fungus B127R mycelium 
The air-dried mycelium was pulverised (53.9 g) and soxhlet extracted with 
chloroform (400 ml) for 16 h to give a brownish gum (7.6 g).  The gum was 
dissolved in warm ethyl acetate (15 ml) and set aside for 24 h.  A white solid (2.3 g) 
was obtained after the solution was filtered off.  TLC studies showed that the solid 
was a cytochalasin since it showed an opaque spot after spraying with diazotized p-
nitroaniline spray reagent.  
1
H NMR and 
13
C NMR spectra (C5D5N) indicated that 
the compound was cytochalasin D, which was isolated and characterised from the 
culture medium of the same fungus.  
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Chapter 3 Secondary metabolites from fungus X.B315 
3.1 Xylaria species B315 Profile  
The fungus coded X.B315 was collected in Thailand and classified as Xylaria 
species.  It was received in Petri dishes as shown in Figure 30.  The front view of the 
Petri dish showed a white mycelium. The reverse side of the fungus was orange with 
black circular spots. 
  
Figure 30 Fungus X.B315 as received from Thailand 
A satisfactory production of secondary metabolites depend on the medium the fungus 
is cultured on; the more complex a medium is, the more chemical diversity the fungi 
will display
17
.  Fungus X.B315 was static sub-cultured at the same time on two 
different media; malt extract-glucose mixture and potato-yeast extract-glucose 
mixture. The fungus was grown into 10 conical flasks (250 ml), five contained an 
aqueous solution of malt extract, whilst the others contained potato based medium. 
The conical flasks were kept under observation for 14 days.  Fungus X.B315 growing 
on malt-extract developed a white mycelium with a black underside, whilst the same 
fungus growing on the potato-yeast extract produced a white fluffy mycelium with a 
pale yellow gelatinous underside. No fruiting bodies formed on either media.  Figure 
31 shows the growth patterns of the fungus on malt and potato extracts after 14 days. 
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                 Malt-extract-glucose    Potato-yeast extract-glucose 
Figure 31  Fungus X.B315 in conical flask after 2 weeks 
 
The fungi were then cultured in (15 x 1 L) Thompson bottles, each bottle containing 
about (500 ml) of the aqueous medium. The mature fungus, which grew on the malt 
extract, produced a white gelatine-like mycelium with black underside, whilst the 
fungus which was cultured on potato-yeast extract produced a cotton-like mycelium 
Figure 32. 
  
                    Malt-extract-glucose  Potato-yeast extract-glucose 
Figure 32 The mycelia of fungus X.B315 
The matured cultures were harvested and the mycelia recovered by filtration through 
a muslin cloth.  The aqueous filtrates of both malt and potato extracts were extracted 
with ethyl acetate using a separating funnel. The solvent fractions were dried over 
anhydrous sodium sulphate. Evaporation of the solvent in vacuo yielded (5.2 g) of 
malt crude extract and (7.2 g) of potato crude extract. 
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The two crude extracts were screened using TLC for their metabolite profile. A 
solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used as eluent. 
Both extracts showed matching patterns of spots under visible and UV light. Under 
visible light, a violet coloured spot appeared at Rf 0.32. Under short wave UV (245 
nm), two active spots were detected; at Rf 0.92 and 0.64. When the TLC plates were 
sprayed with diazotised p-nitroaniline the two spots at (Rf 0.92 and 0.64) developed a 
strong orange colouration, whilst the spot at Rf 0.32 showed a yellowish brown 
colouration.  The spot at Rf 0.32 developed an intense yellow colouration with 
anisaldehyde spray reagent, which turned to red after heating 2-3 min at 110 ºC. 
Comparison of the spot patterns for the metabolite profile for the fungus grown on 
the malt and potato extracts, suggested that both produced the same components. 
3.2 Isolation of secondary metabolites from fungus X.B315 on malt extract 
3.2.1 Isolation of Cytochalasin D  
The ethyl acetate crude extract (5.2 g) was triturated with ethyl acetate and the 
mixture left overnight.  A white precipitate formed which was filtered off and 
recrystallised from methanol to give colourless needles (65 mg), mp 238-240 ºC, ES 
[M+H]
+
 m/z 508.  This compound showed an opaque spot, when treated with 
diazotised p-nitroaniline spray reagent at Rf 0.27 on TLC.  The 
1
H NMR spectrum 
(C5D5N) showed a characteristic N-H signal at δH 9.01. The spectral and physical 
data of this compound confirmed this compound was cytochalasin D the prior 
identification of which is described in Chapter 2. 
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3.2.2 Isolation of R-Mellein  
After removal of cytochalasin D, the ethyl acetate crude extract (3.7 g) was 
chromatographed on four PTLC plates (20 cm x 80 cm); (1 g) on each plate.  Each 
plate was prepared by mixing Merck Kieselgel GPF254 silica gel (100 g) with 
distilled water (270 ml) in a beaker (1 L) and left for 45 min to settle before 
spreading on the clean glass PTLC plate.  After applying the extract on the plate; it 
was developed in a large tank containing toluene, ethyl acetate and acetic acid 
(500:450:10). When elution was complete, the plate was removed and air-dried and a 
band (1.0 cm) at each end of the plate was sprayed with diazotised p-nitroaniline 
spray reagent to detect the bands.  
A UV active band at Rf 0.92 developed a strong orange colouration, when sprayed 
with p-nitroaniline spray reagent suggesting a phenolic compound, but it was not 
active with anisaldehyde spray reagent. The band was recovered and washed with 
ethyl acetate to produce a yellow solution.  
Evaporation of the solvent yielded a yellow oil (35 mg). Trituration of the oil with n-
hexane gave a white solid (12 mg), which was recrystallised twice from the same 
solvent to yield colourless plates (3 mg), mp 52-53°C, ES [M+H]
+
  m/z 179, [α]  -
100º (c 1, in EtOH).  The 
1
H NMR spectrum (CDCl3, Figure 34) shows ten proton 
resonances δH 1.52 (3H, d, J 6.3 Hz), 2.93 (2H, d, J 7.0 Hz), 4.69-4.75 (1H, m), 6.67                                                                                                                                                                                                           
(1H, d, J 7.3 Hz), 6.87 (1H, d, J 8.4 Hz), 7.39 (1H, t, J 7.5 Hz) and 11.02 (1H, s, 
OH). The 3 sets of signals in the aromatic region indicated a 1,2,3- tri-substituted 
ring. The signal at δH 11.02 suggests a chelated hydroxyl group. The signals at δH 
1.52, 4.69 and 2.93 represent a CH3CHCH2 subunit. 
In the 
13
C NMR spectrum (CDCl3, Figure 35) ten carbon  signals comprise a methyl 
at δc  20.88, a methylene at δc 34.73, four methine carbons at δc 76.21, 116.36, 118.00  
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and  136.25 and four quaternaries at 108.41, 139.50, 162.31 and  170.07.  The mass 
spectrum, 
1
H and 
13
C NMR data, suggested a molecular formula of C10H10O3. 
Comparison of the spectral data, mp and the optical rotation of this compound with 
reported data identified this compound as R-mellein
33, 39, 88, 95
 Figure 33. 
O
OOH
CH3
 
Figure 33 R-mellein structure 
1
H,
13
C and DEPT-135 NMR data of mellein is given in Table 9. The structure 
elucidation of mellein is described in more detail in Chapter 2. 
Table 9  
1
H and 
13
C NMR data of R-mellein (CDCl3) 
NO δC δH 
1 170.07-C  
3 76.21-CH 4.69-4.75  (1H, m) 
4 34.73-CH2 2.93 (2H, d,  J  7.0 Hz) 
5 118.00-CH 6.87 (1H, d,  J  8.4 Hz) 
6 136.25-CH 7.39 (1H, t,  J  7.5 Hz) 
7 116.36-CH 6.67 (1H, d,  J  7.3 Hz) 
8 162.31-C  
9 108.41-C  
10 139.50-C  
11 20.88-CH3 1.52 (3H, d,  J  6.3 Hz) 
 * OH group 11.02 (1H, s) 
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Mellein of unidentified stereochemistry was first isolated in 1933 from Aspergillus 
melleus
39, 88
. Later researchers worked out the stereochemistry of mellein. It was 
found to exist naturally in two main forms; R-(-)-mellein and S-(+)-mellein. It has 
been isolated at Bradford from different Xylaria fungi such as X. longiana
33
, X. 
grammica
35
 and X. badia
37
. In this project R-(-)-mellein has been found to be 
produced by the Xylaria fungus B315.   
In Table 10, a summary is presented showing the source and physical properties of 
naturally occurring R-(-)-mellein, which have been reported in the literature. 
Table 10  Source and physical properties of R-(-)mellein reported in literature 
Melting point Optical rotation Source 
56 ºC   [α]   -102º (c 1, CHCl3) Aspergillus onika
95
 
58 ºC    [α]   -100º (c 1, CHCl3) Hypoxylon howieanum
89
 
56-58 ºC [α]   -80º (c 0.02, CHCl3) Aspergillus melleus
39
 
47-48 ºC [α]   -94º (c 0.48, CHCl3) Lasiodiplodia spp.
41
 
57 ºC     [α]   -96º (c 1, CHCl3) Xylaria longiana
33
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3.2.3 Isolation of 4-Hydroxymellein as a stereoisomeric mixture 
The next UV active band on the PTLC plate, which had an Rf   of 0.64, developed a 
strong orange colouration with the p-nitroaniline spray reagent; suggesting a 
phenolic compound. It was isolated as a pale yellow oil and recrystallised from 
petroleum ether (bp 80-100 ºC)  as fine colourless needles (4 mg), mp 121-125 °C, 
ES [M+H]
+
 m/z 195.  
The 
1
H and 
13
C NMR spectra (CDCl3, Figure 37& 38) are characteristic of a mellein-
type molecule, which exists as a mixture of two isomeric forms in unequal ratio 
(3:1).  The C-4 methylene signals of mellein are absent and have been replaced by an 
oxygenated methine signal at δH 4.55/4.56 and δC 67.29/69.19.  Replacement of the 
methylene group with a hydroxyl-methine group at position 4 in mellein molecule 
gives 4-hydroxymellein (C10H10O4).  Comparison of the spectral data for this 
compound with reported data
93, 101
 for 4-hydroxymellein confirms this compound as 
4-hydroxymellein Figure 36.  NMR data of 4-hydroxymellein are listed in Table 11. 
 
O
OOH
CH3
OHH
 
Figure 36 4-Hydroxymellein structure 
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Table 11 NMR data for 4-Hydroxymellein (CDCl3) 
Experimental results    From X. longiana
101
 
NO δC DEPT δH  δC δH 
1 169.29 C   169.24  
1 168.59 C   169.32  
3 78.29 CH 4.60 m  78.30 4.61 qd 
3 80.05 CH 4.57 m  80.02 4.70 q 
4 67.29 CH 4.56 m  67.19 4.61 d 
4 69.19 CH 4.55 m  69.06 4.70 d 
4-OH   2.14 (OH, s)    
5 118.39 CH 6.91 m  118.38 6.95 d 
5 118.60 CH 6.90 m  118.48 7.01 dd 
6 136.89 CH 7.01 m  136.83 7.53 qd 
6 136.97 CH 7.00 m  136.90 7.55 qd 
7 116.35 CH 7.52 m  116.36 7.01 dd 
7 117.87 CH 7.49 m  117.75 6.95 d 
8 162.04 C   161.94  
8 162.14 C   162.02  
9 106.73 C   106.66  
9 106.90 C   106.85  
10 140.58 C   140.54  
10 141.27 C   141.27  
11 16.09 CH3 1.56 (d)  16.02 1.52 (d) 
11 18.00 CH3 1.49 (d)  17.94 1.60 (d) 
* O-H  10.98 (s)   10.99 (s) 
*   10.95 (s)   11.01 (s) 
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The 
1
H NMR spectrum (CDCl3, Figure 37) of the isomeric mixture of cis- and trans-
4-hydroxymellein showed six down-field signals at δH  7.52, 7.49, 7.01, 7.00, 6.91 
and 6.90 and six up-field signals at δH 4.60, 4.57, 4.56, 4.55, 1.56 and 1.49 as well as 
two highly deshielded singlets at δH  10.98 and 10.95.  
The cis-configuration was assigned to H-3 and H-4 on the basis of the small coupling 
constant (2.04 Hz), whereas the analogous trans-isomer had a higher value (4.5 Hz). 
Septoria nodorum
97, 98
, a  phytopathogenic fungus, produces the diastereoisomers cis 
and trans 4-hydroxymelleins.  The isolation of trans-(3R,4S)-4-hydroxymellein from 
Moringa oleifera
98
 was the first report of this metabolite from the stems of a plant 
species. Cercospora taiwanensis
96
,  a well known crop pathogen,  produces cis-
(3S,4S)-4-hydroxymellein in addition to (+)-mellein. The cis-isomer has been 
isolated previously in Bradford from X. longiana
101
, X. grammica
35
 and other Xylaria 
species
87
. In this project, the cis-3R,4R-4-hydroxymellein was isolated from 
endophytic fungi described in Chapter 2.  Different 4-hydroxymellein stereoisomers 
which have been isolated from several fungi are illustrated in Table 12. 
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Table 12 Different 4-hydroxymellein stereoisomers 
Isomer mp/ ºC [α]   Source 
(3R,4R)(-)-cis-form 123-124 -31 Botryospaeria obtuse
102
 
Septoria nodorum
103
 
(3S,4S)(+)-cis-form 131-132 
 
+37 Cercospora taiwanensis
96
 
(3R,4S)(-)-trans-form 131-132 -29 Moringa oleifera
98
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3.2.4 Isolation of Phloroglucinol  
A compound, which gave a violet spot under visible light on the PTLC plate was at 
Rf   0.32,  developed an intense yellow colouration with acetic acid, anisaldehyde and 
sulphuric acid (98:1:1) spray reagent, which turned to red after heating 2-3 min at 
110 ºC.  It was isolated as a brown powder (420 mg) and recrystallised twice from 
water to give colourless crystals (350 mg), mp 214-216 °C, ES [M+H]
+
  m/z 127, 
IRATR  νmaxcm
-1   
3461, 3160, 1609.  The IR absorptions of this compound indicated 
the presence of hydroxyl groups and aromatic C=C band at 1609 cm
-1
.  
In the 
1
H NMR spectrum (acetone-d6, Figure 41) showed only two resonances at δH  
5.84 (3H, s) and three hydroxyl protons as a singlet at δH  8.08 (OH, s).  In the 
13
C 
NMR spectrum (C5D5N, Figure 42) two signals comprise three chemically and 
magnetically equivalent methine carbons at δC 94.55 and three equivalent quaternary 
carbons at δC 159.33.  From the mass spectrum, 
1
H and 
13
C NMR, the molecular 
formula was deduced to be C6H6O3.  The physical and spectral data of this compound 
was compared with the literature data
104
 and identified this compound as 1,3,5-
benzenetriol or phloroglucinol Figure 40. 
ACD/LABS NMR prediction software (v.10) was used to assist the identification of 
the compound. The 
1
H and 
13
C predictors were used to predict the spectra of the 
suggested structure of the compound. The
 
calculated values of the chemical shifts 
were compared and showed good agreement with
 
the
 
experimental values Figure 39. 
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Figure 39 HMQC correlations for phloroglucinol 
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Figure 40 NMR data for phloroglucinol structure 
 
Trihydroxybenzenes are phenolic compounds that are widely distributed in plants. 
They are isolated by extraction but can also be prepared by synthesis. These 
compounds are of great interest in medicinal chemistry because they exhibit, 
antiallergy
105
, antitumor
106
 and antiviral activity
107
.   
A Eucalyptus species, traditionally used as an Indian medicinal plant, were tested for 
its antimicrobial activity against certain drug-resistance bacteria and a yeast Candida 
albicans
108
 An acylated form of phloroglucinol was isolated from Helichrysum 
caespititium
109
.  This compound inhibits the growth of the Gram-positive bacteria 
such as Bacillus cereus and Staphylococcus aureus and also inhibits the growth of 
Gram-negative
 
bacteria
 
 such as Escherichia coli and Pseudomonas aeruginosa
109
.  
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Phloroglucinol or 1,3,5-benzenetriol derivatives, which have been isolated from the 
aerial parts of Hypericum calycinum
110
 shows fungicidal activity against 
Cladosporium cucumerinum , and antimalarial activity in an in vitro test system. 
Also, derivatives of phloroglucinol have been isolated and identified from the marine 
algae genus Zonaria
111
.  This appears to be the first report of the isolation of 
phloroglucinol from a Xylaria species. 
3.3 Isolation of Phloroglucinol from X.B315 mycelium 
The air-dried mycelium was pulverised (65.5 g). The sample was packed into a 
soxhlet thimble, which was placed into a soxhlet apparatus. It was extracted with 
chloroform (400 ml) for 16 h. After the evaporation of the solvent in vacuo a brown 
crude extract (5.6 g) was obtained.  
The extract was then analysed for its content using TLC.  A solvent system of 
toluene, ethyl acetate and acetic acid (50:49:1) was used as eluent. A visible violet 
spot was detected on a TLC plate at Rf 0.32.  The spot developed a yellowish brown 
colouration with p-nitroaniline spray reagent, whilst it showed a yellow colouration 
with anisaldehyde spray reagent, which turned to red after heating 2-3 min at 110 ºC. 
The crude extract was warmed with H2O (15 ml) for 10 min. The solution was 
filtered off and filtrate was left to cool.  Colourless crystals of phloroglucinol formed 
(450 mg).  It appears that phloroglucinol is a major secondary metabolite produced 
by fungus X.B315. 
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3.4 Secondary metabolites from fungus X.B315 on potato-extract 
Analogous procedures to those described above for the isolation of secondary 
metabolites of X.B315 grown on malt extract-glucose were applied to the ethyl 
acetate crude extract of the same fungus grown on potato medium.  It was found that 
fungus X.B315 grown on potato-yeast extract-glucose mixture produced the same 
secondary metabolites, but in higher yield. The mycelium of this fungus also 
produced phloroglucinol.  The yields of the metabolites produced by fungus X.B315 
on different media are summarised in Table 13.  
Table 13 Yields of metabolites produced by fungus X.B315 
Metabolites Malt-extract Potato-extract 
Cytochalasin D 65 mg 113 mg 
R-Mellein 3 mg 12 mg 
4-Hydroxymellein stereo-isomeric mixture 4 mg 7 mg 
Phloroglucinol 350 mg 419 mg 
Phloroglucinol from X.B315 mycelium 450 mg 570 mg 
 
 
 
 
 
 
 
 
                      Chapter 4 
78 
 
Chapter 4 Secondary metabolites from fungus X.62 
4.1 Xylaria endophyte X.62 Profile 
The fungus coded X.62 was isolated from palm tree leaves in Thailand and classified 
as a Xylaria endophyte.  It was received in Petri dishes as shown in Figure 43. The 
front view of the Petri dish showed a white mycelium. The reverse side of the fungus 
was also white; but with a black ring round the edge of the dish.  
 
Figure 43 Fungus X.62 as received from Thailand 
The fungus was static sub-cultured into four conical flasks (250 ml). It produced a 
white mycelium after 2 weeks. The fungus was then cultured on a malt-yeast extract 
glucose mixture into Thompson bottles (15 x 1L) for 8 weeks.  During the first 4 
weeks it grew as a white mycelium with black areas underside. 
The matured cultures were harvested and the mycelia were recovered by filtration 
through a muslin cloth and left to air-dry.  The aqueous filtrate was extracted with 
ethyl acetate in a separating funnel (5 L). The ethyl acetate fraction was dried over 
anhydrous sodium sulphate.  After the removal of the solvent, a brown crude extract 
was obtained (1.2 g).   
TLC analysis of the crude extract was conducted in different solvent systems.  The 
resultant plates showed that the solvent systems; toluene, ethyl acetate and acetic 
acid (50:49:1), chloroform and methanol (95:5) and petroleum ether (bp 60-80
o
C), 
ethyl acetate and acetic acid (50:49:1) showed that the crude extract contained a 
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complex mixture of different components with different Rf values. When the plates 
were sprayed with p-nitroaniline spray reagent opaque spots were revealed. 
1
H NMR 
spectroscopy (C5D5N) showed that the crude extract contained a mixture of 
cytochalasins according to four N-H signals.  Several attempts to isolate these 
compounds by chromatographic techniques failed. 
4.2 Isolation of secondary metabolites from fungus X.62 mycelium 
4.2.1  Isolation of 19,20-Epoxycytochalasin C  
The air-dried black mycelium (79.3 g) was pulverised. The powdered mycelium was 
packed firmly into a soxhlet thimble, which was placed into a soxhlet apparatus. The 
mycelium sample was extracted with chloroform (400 ml) for 16 h.  After the 
evaporation of the solvent in vacuo, a brown gummy solid was obtained (5.0 g). The 
extract was then analysed for its content by TLC.  
A solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used as 
eluent.  Visualization under short wave UV (245 nm) showed a single spot with Rf 
0.42. When the TLC plate was sprayed with p-nitroaniline reagent an opaque spot 
was observed at Rf 0.42, which indicated that the compound was likely to be a 
cytochalasin.  The ethyl acetate extract was triturated with ethyl acetate and left 
overnight.  A white solid was obtained. The solid was filtered off and recrystallised 
from methanol to yield white needles, mp 266-270 °C, ES [M+H]
+
  m/z  524, [α]  -
6.4º (c 1, in CHCl3).  The IRATR spectrum of this compound showed absorptions at: 
3423, 1744 and 1697 cm
-1
, which suggested the presence of the following groups, a 
hydroxyl, a carbonyl ester and an amide. 
The 
1
H NMR spectrum (C5D5N, Figure 49) of this compound gave the general 
appearance of that expected for a cytochalasin.  A molar mass of 523 further 
supported this conclusion.  The spectrum showed five methyl signals; one doublet at 
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δH 0.98 and four singlets at δH 1.24, 1.59, 1.83, 2.10 and a N-H singlet signal at δH 
9.46, which is characteristic for a cytochalasin structure. The spectrum is different to 
that of cytochalasin D, which was discussed in Chapter 2.  The absence of the 
alkene protons at δH 5.04 and 5.40 (12-Ha & 12-Hb) and the associated carbon signal 
at δC 112.16 (CH2, C-12) confirmed that this compound is not cytochalasin D. 
The presence of five methyl groups in a pattern of a doublet and four singlets 
suggested that this compound could be related to cytochalasin C Figure 44.   
HN
O
OAc
H3C
CH3
H
OH
H
OHH3C
CH3
 
Figure 44 Cytochalasin C 
The unknown compound has a molar mass of 523, whilst cytochalasin C has a molar 
mass 507.  The difference of 16 mass units strongly pointed to the presence of an 
additional oxygen. 
The 
13
C NMR spectrum (C5D5N, Figure 50) of this compound presents 28 carbon 
signals. The signals at δC 128.84 and 129.88 are double the height of other peaks 
signifying that these signals are each due to two carbon atoms to give a total of 30 
carbons as found in cytochalasin C.  Comparison of the 
13
C NMR spectral data for 
cytochalasin C
25
 and this unknown Table 16 revealed that the carbon signals 
associated with 19,20 C=C were absent and that there were two additional methine 
signal at δC 54.11 and 61.45 indicative of sp
3
 carbons attach to oxygen.  This 
information together with the presence of additional oxygen suggested that the 19,20 
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double bond was now epoxidized, indicative of the unknown being 19,20-
epoxycytochalasin C Figure 45. 
HN
O
OAc
H3C
CH3
H
OH
H
OHH3C
CH3O
H
H  
Figure 45 19,20-Epoxycytochalasin C 
 
1
H and 
13
C NMR data of this cytochalasin are presented in Table 15. 
It is not possible from the spectral data for the double bond to be at position C-13 and 
C-14. The chemical shift of the N-H proton of the lactam ring in cytochalasin 
compounds appears generally above δH 9.0, when pyridine-d5 is used as the NMR 
solvent. It has been observed that the signal for this proton can be characteristic for 
cytochalasin.  In 19,20-epoxycytochalasin C for instance, the N-H proton resonates 
at δH 9.46, which is the case for the isolated cytochalasin.   
Table 14 shows the characteristic physical data of some epoxycytochalasins. 
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Table 14  Characteristic physical data of some epoxycytochalasins
25,110
 
Epoxycytochalasins [α] m/z 
19,20-epoxycytochalasin  R -60º 524 
19,20-epoxycytochalasin  N -55º 540 
19,20-epoxycytochalasin  C -300º 524 
19,20-epoxycytochalasin  D -228º 524 
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Table 15 NMR data of 19,20-epoxycytochalasin C (C5D5N) 
NO δH δC DEPT 
1  175.35 C 
2 9.46 (1H, s) NH  
3 3.59 (1H, t, J  7.2 Hz) 50.08 CH 
4 3.17 (1H, d, J  7.3 Hz) 51.03 CH 
5  126.58 C 
6  133.72 C 
7 4.40 (1H, s) 68.89 CH 
7-OH 4.97 (1H, s)   
8 2.16 (1H, s) 52.82 CH 
9  60.75 C 
10 2.82-2.84 (2H, m) 45.28 CH2 
11 1.83 (3H, s) 14.78 CH3 
12 1.24 (3H, s) 17.06 CH3 
13 5.85-5.89 (1H, m) 132.21 CH 
14 6.73-6.77 (1H, m) 132.89 CH 
15a 1.94 (1H, dd, J 11.1,12.2 Hz) 38.35 CH2 
15b 2.60-2.63 (1H, m)   
16 2.85-2.88 (1H, m) 42.00 CH 
17  216.19 C 
18  77.16 C 
19 3.75 (1H, s) 54.11 CH 
20 4.20 (1H, s) 61.45 CH 
21 6.26 (1H, s) 73.36 CH 
22 0.98 (3H, d, J  6.5 Hz) 19.05 CH3 
23 1.59 (3H, s) 20.38 CH3 
24  170.84 C 
25 2.10 (3H, s) 22.55 CH3 
1’  138.74 C 
2’,6’ 7.20-7.35 (2H, m) 129.88 CH 
3’,5’ 7.20-7-35 (2H, m) 128.84 CH 
4’ 7.20-7.35 (1H, m) 126.81 CH 
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Table 16 
13
C NMR of 19,20-epoxycytochalasin C and cytochalasin C 
NO 19,20-Epoxycytochalasin C Cytochalasin C
25
 
1 175.35 175.71 
2 NH NH 
3 50.08 50.71 
4 51.03 50.71 
5 126.58 126.69 
6 133.72 134.06 
7 68.89 69.13 
8 52.82 53.76 
9 60.75 61.05 
10 45.28 42.54 
11 14.78 14.92 
12 17.06 17.29 
13 132.21 130.00 
14 132.89 132.93 
15 38.35 38.72 
16 42.00 42.54 
17 216.19 210.94 
18 77.16 78.62 
19 54.11 132.78 
20 61.45 133.54 
21 73.36 76.39 
22 19.05 19.49 
23 20.38 20.71 
24 170.84 170.93 
25 22.55 24.77 
1’ 138.74 138.99 
2’,6’ 129.88 129.07 
3’,5’ 128.84 128.60 
4’ 126.81 127.04 
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Cytochalasins are fungal metabolites which have been isolated from different genera 
of fungi such as Phomopsis, Chaetomium, Hypoxylon and most recently from Xylaria 
and Daldinia
30
. Cytochalasins exhibit several biological activities including marked 
cytostatic effects on mammalian cells in tissue cultures
112,113
, antibiotic and 
antitumor activity
114
.  
19,20-Epoxycytochalasin C is a natural product.  It was isolated and identified  from 
the fungus Xylaria hypoxylon
30
 alongside 19,20-epoxycytochalasin Q, 19,20-
epoxycytochalasin R, 19,20-epoxycytochalasin D and 19,20-epoxycytochalasin N 
Figure 46. 
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19,20-Epoxycytochalasin Q 19,20-Epoxycytochalasin R 
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19,20-Epoxycytochalasin D 19,20-Epoxycytochalasin N 
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19,20-Epoxycytochalasin C 
Figure 46 Epoxycytochalasins from X. hypoxylon 
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Dagne
115
 et al  reported the isolation and characterisation of two new   
epoxycytochalasins; 19,20-epoxycytochalasinQanddeacetyl-19,20-epoxycytochalasin 
Q  from  Xylaria obovata, a tropical fungus was collected from the Munsea forest in 
Ethiopia Figure 47. 
HN
O
CH3
O
OHH3C
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OAc
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H3C
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19,20-Epoxycytochalasin Q Deacetyl-19,20-epoxycytochalasin Q 
Figure 47 Epoxycytochalasins from X. obovata 
Another group of workers, Abate
116
 et al isolated 19,20-epoxycytochalasin C, 
deacetyl-19,20-epoxycytochalasin C and xylobovatin from cultures of the same 
fungus Figure 48. 
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19,20-Epoxycytochalasin C Deacetyl-19,20-
epoxycytochalasin C 
Xylobovatin 
Figure 48 Epoxycytochalasins from X. obovata 
19,20-Epoxycytochalasin C has been isolated previously in Bradford University from 
Rosellinia arcuata
37
.  In this project this compound has been isolated from 
endophytic Xylaria species. 
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Chapter 5 Secondary metabolites from the fungus Engleromyces sinensis  
5.1 Engleromyces sinensis  
The samples of this fungus, which  belongs to the family Hypocreaceae were 
collected on Snow Mountain at ca 2700 m, Lijiang, Yunnan province in China
117
.  It 
was classified as Engleromyces sinensis Figure 52, a species which is highly 
distributed in Yunnan province, on bamboo stems in Yulong mountain, China.  It is 
the second species in the genus after  Engleromyces goetzei
118
. 
 
Figure 52 Fungus Engleromyces sinensis as received from China 
Engleromyces sinensis is described as new and its distinguishing characteristics are 
contrasted with those of Engleromyces goetzei, which is found in East Africa
117
.  The 
fungus had yellowish flesh with a hard yellowish –brown exterior crust Figure 52. 
The old herbarium material was hard and horny, but became soft when soaked in 
water. Morphological examination and a taxonomic study has been reported by 
Whalley et al
117
 in order to determine the characteristic features. 
The hard crust of the fungus was cut into pieces and pulverised using a grinder.  The 
powdered sample (60.5 g) was packed firmly into a soxhlet thimble, which was 
placed in a soxhlet apparatus.  The sample was extracted successively with four 
different solvents (400 ml of each) for 24 h.  The hexane fraction yielded yellowish 
oil (1.4 g), whilst the chloroform fraction yielded a light brown gum (0.5 g).  Ethyl 
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acetate fraction yielded a light brown gum (43 mg) and methanol fraction yielded a 
dark brown gum (7.1 g). 
The different extracts were then examined for their metabolite profile by TLC.  A 
solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used as eluent. 
Hexane extract showed a UV active spot Rf 0.9, whilst chloroform extract did not 
show any UV active spots.  Ethyl acetate and methanol extracts showed matching 
patterns of a single spot under UV Lamp at Rf 0.32.  When the TLC plates of both 
these extracts were sprayed with p-nitroaniline spray reagent the spot developed an 
opaque colouration, suggesting that the ethyl acetate and methanol extracts contained 
the same component. 
5.2 Isolation of secondary metabolites from fungus Engleromyces sinensis 
5.2.1 Isolation of Engleromycin acetate  
A white precipitate formed in the ethyl acetate extract.  The white solid (23 mg) was 
filtered off and recrystallised twice from ethyl acetate to yield colourless needles, mp 
265-269 °C, ES [M+H]
+ 
 m/z 524, [α]  -220º (c 1, in CHCl3).  This compound 
showed an opaque spot when treated with diazotised p-nitroaniline spray reagent at 
Rf 0.32 on TLC.  The IRATR spectrum of this compound showed distinguishable 
signals: 3748, 3378, 1754 and 1670 cm
-1
, which could indicate the presence of the 
following: hydroxyl, amino, carboxylic ester and amide functional groups. 
1
H NMR spectrum (C5D5N, Figure 57) of this compound was indicative of a 
cytochalasin which showed N-H resonance position at 9.13 in the 
1
H NMR spectrum.  
In the 
13
C NMR and DEPT-135 spectra (C5D5N, Figure 58 & 59) an exocyclic 
methylene signal at δC 112.03 and two possible alkene protons at δH 5.27 and 5.59 in 
the 
1
H NMR spectrum suggested that this cytochalasin (m/z  M
+  
523) could be 
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related to cytochalasin D (m/z  M
+  
507) Figure 53.  The difference of 16 mass unit 
suggested an additional oxygen atom is present. 
 
HN
O
O
CH3
OAc
OHH3C
CH2
H
OH
H
H3C
 
Figure 53 Cytochalasin D 
The compound has four methyl groups; which appear as two singlets at δH 1.51 and 
2.07 and two doublets at δH 0.58 and 0.91, which again points to a cytochalasin D 
related molecule. 
The 
13
C NMR and DEPT-135 spectra of this compound present 28 carbon signals.  
The signals at δC 128.77 and 129.97 are double height of other peaks signifying that 
these signals are each due to two carbon atoms, to give a total of 30 carbons as in 
cytochalasin D. 
Comparison of the NMR spectral data for cytochalasin D Chapter 2 and the NMR 
data of this compound revealed striking changes in the resonances associated with 
19,20 region of the molecule as shown in the Table 17.  
Table 17  Comparison of NMR data in 19,20 region of  the two cytochalasins 
No Cytochalasin D Unknown cytochalasin 
 δC δH δC δH 
19 132.18 5.59 54.37 3.65 
20 133.81 6.83 60.70 4.23 
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The resonances at δH  3.65  and 4.23  and δC  54.37 and 60.70 indicates that the two 
19,20- methine protons are attached to oxygen atom bearing carbons.  This data 
confirms the presence of an epoxide at C-19 and C-20 instead of the carbon-carbon 
double bond present in cytochalasin D.   
The presence of the epoxide group at C-19,C-20 and an exocyclic  methylene group 
at C-12 suggests that this compound is the epoxide derivative of cytochalasin D, 
which is known as 19,20-epoxycytochalasin D
30
 or engleromycin acetate
26
 Figure 
54.  
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Figure 54 Engleromycin acetate 
The chemical shift of the N-H proton of the lactam ring in cytochalasin D appears at 
δH 9.08, when pyridine-d5 is used as the NMR solvent whilst, the N-H resonance of 
engleromycin acetate is at δH 9.13.  ID and 2D NMR experiments were used to 
determine the assignments of the NMR data Table 18. 
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Table 18 
1
H, 
13
C and DEPT assignments for engleromycin acetate (C5D5N) 
No δH δC DEPT 
1  175.04 C 
2 9.13 (1H, s) NH  
3 3.46 (1H, s) 53.96 CH 
4 2.45 (1H, s) 50.57 CH 
5 3.00-3.10 (1H, m) 32.93 CH 
6  151.39 C 
7 4.32(1H, d, J 10.3 Hz) 71.37 CH 
7-OH 4.86 (1H, s)   
8 3.20 (1H, s) 47.33 CH 
9  53.66 C 
10 2.80-2.89 (2H, m) 45.43 CH2 
11 0.58 (3H, d, J  6.6  Hz) 13.36 CH3 
12a 5.27 (1H, s) 112.03 CH2 
12b 5.59 (1H, s)   
13 5.91-5.96 (1H, m) 132.04 CH 
14 6.49-6.56 (1H, m) 132.53 CH 
15a 1.91 (1H, d, J 6.5 Hz) 38.19 CH2 
15b 2.71-2.76 (1H, m)   
16 2.77-2.79 (1H, m) 42.46 CH 
17  216.37 C 
18  77.30 C 
19 3.65 (1H, d, J 2.5 Hz) 54.37 CH 
20 4.23 (1H, d, J 2.5 Hz) 60.70 CH 
21 6.16 (1H, s) 75.11 CH 
22 0.91 (3H, d, J 6.5 Hz) 18.95 CH3 
23 1.51 (3H, s) 20.36 CH3 
24  170.62 C 
25 2.07 (3H, s) 22.71 CH3 
1’  138.38 C 
2’,6’ 7.20-7.35 (2H, m) 129.97 CH 
3’,5’ 7.20 -7.35 (2H, m) 128.77 CH 
4’ 7.20-7.35 (1H, m) 126.78 CH 
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Engleromyces is a genus that belongs to Hypocreaceous fungi
117
.  Engleromyces, has 
two species;  Engleromyces goetzei
117
 which grows on the upper stems of the high 
mountains bamboo in Kenya, East Africa as well as in Yunnan in China.  On the 
other hand, Engleromyce sinensis
117
, the second species in the genus, occurring on 
bamboo stems in Yunnan and Scihuan Province in China.  
Little attention has been paid to the chemical constituents of this inedible fungus. A 
novel N-containing compound, neoengleromycin Figure 55 alongside two known 
cytochalasins;  cytochalasin D and 19,20-epoxycytochalasin D were  isolated from 
the fruiting bodies of Engleromyces goetzei
26,27
 which was collected from Lijiang, 
Yunnan province in China. 
O O
N
O
O O
OHN
O
 
Figure 55 Neoengleromycin 
Another group of workers, Pedersen
119
 et al isolated engleromycin; an epoxide of 
cytochalasin D from the cultures of Engleromyces goetzei  Hennings collected from 
Kenya Figure 56.  
HN
O
O
OHH3C
O
OH
CH2
H3C OH
HH
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Figure 56 Engleromycin structure 
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Engleromycin acetate has been isolated previously at Bradford from the cultures of 
fungus Rosellinia arcuata
120
.  In this project, engleromycin acetate was isolated from 
fungus Engleromyces sinensis. 
The medicinal uses of Engleromyces sinensis in China is to treat illnesses due to its 
antiinflammatory and antimicrobial properties
117
,  whilst  Engleromyces goetzei
117
 
has been used in traditional African medicine for the treatment of the fever 
associated with malaria. Engleromyces goetzei
26
, which grows on the bamboo of high 
mountains is used in the treatment of infection and cancer diseases in the area around 
Tibet of China including Yunnan and Sichuan Provinces. 
  
                      Chapter 5 
97 
 
 
 
 
  
N
H
 
F
ig
u
re
 5
7
 1
H
 N
M
R
 s
p
ec
tr
u
m
 o
f 
en
g
le
ro
m
y
ci
n
 a
ce
ta
te
 
                      Chapter 5 
98 
 
 
F
ig
u
re
 5
8
  
1
3
C
N
M
R
 s
p
ec
tr
u
m
 o
f 
en
g
le
ro
m
y
ci
n
 a
ce
ta
te
 
                      Chapter 5 
99 
 
F
ig
u
re
  
5
3
  
D
E
P
T
-1
3
5
 s
p
ec
tr
u
m
 o
f 
 e
n
g
le
ro
m
y
c
in
 a
ce
ta
te
 
F
ig
u
re
 5
9
 D
E
P
T
-1
3
5
 s
p
ec
tr
u
m
 o
f 
en
g
le
ro
m
y
ci
n
 a
ce
ta
te
 
                      Chapter 5 
100 
 
F
ig
u
re
 6
0
 H
M
Q
C
 s
p
ec
tr
u
m
 o
f 
en
g
le
ro
m
y
ci
n
 a
c
et
a
te
 
F
ig
u
re
 6
0
 H
M
Q
C
 s
p
ec
tr
u
m
 o
f 
en
g
le
ro
m
y
ci
n
 a
c
et
a
te
 
                      Chapter 6 
101 
 
Chapter 6 Secondary metabolites from the fungus X. polymorpha 
6.1 Fungus X. polymorpha  
The fungus X. polymorpha, which is a plant pathogen, was collected in Thailand.  It 
was received in Petri dishes as shown in Figure 61.  The front and the back views of 
the Petri dish revealed a white mycelium.  
  
Figure 61 Fungus X. polymorpha as received from Thailand 
The fungus was static sub-cultured for two weeks into 5 conical flasks (250 ml) 
containing an aqueous malt extract medium. The fungus developed light brown 
cylindrical shaped-stromata with unbranched white tips.  It produced a white 
mycelium with a light brown gelatinous underside Figure 62.  
 
Figure 62 Fungus X. polymorpha in a flask after 2 weeks 
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The fungus was then cultured in Thompson bottles (15 x 1 L), each bottle containing 
about (500 ml) of a malt-yeast extract-glucose mixture for 8 weeks. The fungus 
during the first 4 weeks produced a cotton-like mycelium Figure 63. 
 
Figure 63 The mycelium of fungus X. polymorpha 
The matured cultures were harvested and the mycelia were recovered by filtration 
through a muslin cloth.  The aqueous filtrate was extracted with ethyl acetate using a 
separating funnel (5 L).  The ethyl acetate extracts were combined and  dried over 
anhydrous sodium sulphate.  Evaporation of the solvent  in vacuo yielded  the crude 
extract (2.3 g). 
The composition of the crude extract was examined using TLC in different solvent 
systems; toluene, ethyl acetate and acetic acid (50:49:1), chloroform and methanol 
(95:5) and petroleum ether (60-80 ºC), ethyl acetate and acetic acid (30:70:1). The 
resultant plates showed that the crude extract contained a single spot with Rf 0.4.  
When the TLC plate was sprayed with p-nitroaniline spray reagent, it developed an 
orange colouration. The mycelium contained insignificant quantities of metabolites. 
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6.2 Isolation of secondary metabolites from fungus X. polymorpha 
6.2.1   Isolation of (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’-methylphenyl)-2-
methoxybut-3-enoic acid 
The component recovered (tubes 20-55) was a yellow oil,  which was triturated 
with ethyl acetate to give a white solid (13 mg), which was recrystallised from the 
same solvent to yield colourless crystals (7 mg), mp 160-163°C, ES [M+H]
+
 m/z 
281, IRATR νmax cm
-1 
3300, 1774 and 1628.  The compound had  a Rf  value of 0.4 
on a silica gel TLC plate eluted with petroleum ether (60-80 ºC), ethyl acetate and 
acetic acid (30:70:1).  It showed an intense orange spot with diazotised p-
nitroaniline spray reagent, suggesting the compound was a phenolic.  
The 
1
H NMR spectrum (C5D5N, Figure 72) showed 3 singlet methyl signals at δH 
2.28, 2.43 and 3.48.  A down field methine proton at δH 4.79 (1H, dd, J 6.6, 1.1 Hz)  
indicating that this proton could be attached to carbon attached to an oxygen atom.  
A singlet signal for a methine proton in the aromatic region at δH  7.49.  Two alkene 
protons, as indicated by the 16.2 Hz trans coupling constant at δH 7.60 (1H, dd, J 
16.2, 6.6 Hz) and 7.75 (1H, dd,  J 16.2, 1.1 Hz).  A strongly chelated-OH at δH 14.06 
suggesting that the hydroxyl group is intramolecularly hydrogen bonded to the 
carbonyl oxygen. 
The 
13
C NMR spectrum (C5D5N, Figure 73) showed 14 signals comprised of three 
methyl carbons  at  δC 17.08, 26.08 and 56.95.  The methyl group at δC 56.95 
suggests it is attached to oxygen atom.  Four methine carbons at δC 83.58, 124.07 
129.91 and 132.35.  Five quaternary carbons in the aromatic region which occur at δC 
112.35, 113.02, 116.80, 162.27 and 162.70. The quaternary carbon at at δC 203.37 is 
a typical carbonyl of a ketone.  The mass spectrum, 
1
H and 
13
C NMR suggested a 
molecular formula of C14H16O6.  
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The 
1
H-
1
H COSY spectrum (C5D5N, Figure 75) showed a single spin system. The 
doublet of doublet methine proton at δH 4.79, showed a connectivity to the alkene 
protons at δH  7.60, which in turn is trans coupled (J 16.2 Hz) to the one proton 
doublet of doublets at δH  7.75, which gives sub-unit A Figure 64 . 
H
R H
O
H
7.75
7.60
4.79
 
Figure 64 Sub-unit A 
The lack of proton coupling information meant that the HMBC spectrum, in 
association with the HMQC spectrum, played a pivotal role in establishing a 
structural formula.  The proton signal at δH  4.79 showed 4 long range correlations, 
which led to sub-unit B  Figure 65 . 
H
R H
O
H COOH
7.75
7.60
4.79
CH3
173.63
83.58
56.95
3.48
124.07 129.91
 
Figure 65 Sub-unit B 
The molecular formula of C14H16O6 indicated an index of hydrogen deficiency (IHD) 
of  7 and sub-unit B only contains two degrees of unsaturation.  Thus the partial 
structure that remains has an (IHD) of 5, which given the presence of an acetyl group 
(3 proton singlet at δH 2.43) strongly indicated the presence of a benzene ring; 
probably penta-substituted (1 acetyl, 2 hydroxyl, 1 methyl and Sub-unit-B. 
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The downfield singlet at δH 14.06 was strongly indicative of intramolecular hydrogen 
bonding and led to sub-unit C Figure 66. 
2.43
203.37
H3C
CH3HO
Sub-unit B
H
O
2.28
OH
14.06  
Figure 66 Sub-unit C 
The positioning of the substituents was established by careful analysis of the HMQC 
and HMBC 2D NMR data, which gave sub-unit D  Figure 67. 
14.06
162.27
162.70
112.35
116.8
2.28
17.08
2.43
26.09
132.36
113.02
203.37
7.49
Sub-unit B
H3C
CH3
H
OHO
OH
 
Figure 67 Sub-unit D 
Fusion of sub-units B and D led to the structure of this metabolite; (3E)-4-(3’-acetyl-
2’,6’-dihydroxy-5’-methylphenyl)-2-methoxybut-3-enoic acid  Figure 68. 
H3C
CH3
H
OHO
OH
COOH
OCH3
1
2
3
4
5
1'
2'
3'
4'
5'
6'
7'
8'
 
Figure 68 (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’-methylphenyl)-2-methoxybut-3- 
enoic acid structure  
The NMR assignments for the compound, which were established using 1D and 2D 
NMR spectral experiments are presented in Table 19 & 20.  
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Table 19 
1
H and 
13
C NMR data for (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’-
methylphenyl)-2-methoxybut-3-enoic acid (C5D5N) 
No  δH δC DEPT 
1  173.63 C 
2 4.79 (1H, dd, J 6.6, 1.1 Hz) 83.58 CH 
3 7.60 (1H, dd, J 16.2, 6.6 Hz) 129.91 CH 
4 7.75 (1H, dd, J 16.2, 1.1 Hz) 124.07 CH 
5 3.48 (3H, s) 56.95 CH3 
1’  112.35 C 
2’  162.27 C 
3’  113.02 C 
4’ 7.49 (1H, s) 132.35 CH 
5’  116.80 C 
6’  162.70 C 
7’  203.37 C 
8’ 2.43 (3H, s) 26.08 CH3 
9’ 2.28 (3H, s) 17.08 CH3 
2’-OH 14.06 (1H, s)   
 
Table 20 HMBC
 
NMR data for (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’-
methylphenyl)-2-methoxybut-3-enoic acid (C5D5N) 
No  δH δC  
n
JH-C correlation ex 
HMBC 
2 4.79 (1H, dd, J 6.6, 1.1 Hz) 56.95,124.07,129.91,173.63 
3 7.60 (1H, dd, J 16.2, 6.6 Hz) 83.58,112.35 
4 7.75 (1H, dd, J 16.2, 1.1 Hz) 83.58, 162.27, 162.70 
5 3.48 (3H, s) 83.58 
4’ 7.49 (1H, s) 17.08, 162.27, 162.70, 203.37 
8’ 2.43 (3H, s) 113.02, 132.35, 203.37 
9’ 2.28 (3H, s) 132.35, 162.70, 113.02 
2’-OH 14.06 (1H, s) 113.02, 162.70 
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A  literature  search  revealed that the isolation of this compound has been reported 
previously
34
 by Edwards et al  in 1995.  They isolated Globoscin (1) and Globoscinic 
acid (2) Figure 69 from the culture media of the fungus X. globosa, which was 
collected from a forest in the Cameron.  During the course of that work they found 
that Globoscin (1) rearranged slowly in pyridine to give (3E)-4-(3’-acetyl-2’,6’-
dihydroxy-5’-methylphenyl)-2-methoxybut-3-enoic acid.  Since deuteropyridine was 
used as the NMR solvent in this work, it is highly likely that the product identified is 
in fact also a rearrangement product. 
CH3
OH
OH O
O
OCH3
H3C
O
 
H3C
OH
O
CH3
OH
OH OH OCH3
O
 
Globoscin (1) Globoscinic acid (2) 
Figure 69 Secondary metabolites from X. globosa and X. obovata 
  Xylaria  polymorpha, a hard wood-colonizing Ascomycete, commonly known as 
dead man’s fingers, is a plant pathogen121.   It is a common inhabitant of forest and 
woodland areas, usually growing from the bases of rotting or injured tree stumps and 
decaying wood.  It is distributed worldwide in tropical areas, produces various 
secondary metabolites that exhibit potential biological activities.   
Three isopimarane diterpene glycosides; 16-α-D-mannopyranosyloxyisopimar-7-en-
19-oic-acid (3), 15-hydroxy-16- α-D-mannopyranosyloxyisopimar-7-en-19-oic-acid 
(4) and 16- α-D-glucopyranosyloxyisopimar-7-en-19-oic-acid (5) Figure 70 , have 
been isolated from the fruiting bodies of the fungus  Xylaria  polymorpha
122
, which 
was fermented on an unpolished rice media. 
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Compound (3) Compound (4) 
COOH
O
O
OH
OH
OH
OH  
Compound (5) 
Figure 70 Secondary metabolites from X. polymorpha 
The new diterpene derivatives showed cytotoxicity against human cancer cell lines 
and exhibited IC50 values ranging from 71-607 µM. 
Jang  et al 
123
 have identified the chemical constituents of the fruiting bodies of 
Xylaria polymorpha.  Linoleic acid (6), linoleic acid methyl ester (7), 4-acetyl-3,4-
dihydro-6,8-dihydroxy-3-methoxy-5-methyl-1H-2benzopyran-1-one(8),4-
hydroxyscytalone (9) and ergosterol (10) were isolated from its methanolic extract 
Figure 71. 
CH2(CH2)5CH2COOHH3C(H2C)3H2C
 
CH2(CH2)5CH2COOCH3H3C(H2C)3H2C
 
Compound (6) Compound (7) 
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HH
HO  
Compound (10) 
Figure 71 Secondary metabolites from X. polymorpha 
Laccase
124
 is a ligninolytic oxidoreductase enzyme produced by the fungus Xylaria 
polymorpha, which was fermented on tomato juice complex medium. The enzyme has 
a potential ability to modify non-phenolic lignin structures in the presence of suitable 
mediators.  Also, it may be involved in the melanization process (formation of 
melanin in wood).  Hacioglu et al
121
 have examined the antimicrobial potential of the 
ethanolic extracts obtained from the macro-fungus  Xylaria polymorpha using agar 
disc diffusion assays. The fungus showed a significant antimicrobial activity against 
Gram-positive and Gram-negative bacteria as well as the yeast cultures. 
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Chapter 7   Experimental Work 
7.1 Culturing of Fungi 
7.1.1 Culture Room 
The fungi used in this project were cultured in a special room under specific 
conditions. The culture room was equipped with the following essentials: 
- An autoclave for sterilising the culture media before inoculation. 
- A Bunsen burner to sterilise glasses and tools such as spatulas used during   
the culturing process. 
- A thermostatic heating system to keep the culture room at stable temperature 
suitable for fungi growing. 
- A thermometer to monitor room temperature. 
 7.1.2 Glassware inside the culture room 
- Thompson bottles (1 L) and (2 L) to grow the fungi on a large scale. 
- Conical flasks (250 ml) to grow the fungi on a small scale. 
- Sample tubes with a screw cap to save master cultures of the fungi on agar 
slopes. 
7.1.3 Sterilisation 
Sterilisation is the process that is used to kill microorganisms such as yeast, bacteria, 
fungi and viruses on a surface, equipment and the biological culture media. This 
process was achieved using a chemical detergent and heating under elevated 
temperature and pressure as follows: 
- First of all, the conical flasks and Thompson bottles were cleaned with water 
and a biocleaner detergent (2.5 % solution of Microcleanse from Teknon) 
using a cleaning brush. 
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- After preparation of the culture medium, a Priorclave was used to sterilise the 
flasks and Thompson bottles containing the culture medium. The Priorclave 
uses steam at 121ºC for 30 min. The process is completely automated in this 
modern autoclave Figure 78. 
 
Figure 78  The Priorclave used in sterilisation 
 
7.1.4 Master culture 
Master cultures of the fungi were kept in 20 ml glass screw-capped tubes. They were 
prepared as follows: 
- An aqueous suspension of 3% malt and 2% bio-agar was mixed with heating. 
- 20 ml sample tubes with cap were filled to approximately half their volumes 
with the prepared suspension. 
- The tubes and contents were sterilised by the Priorclave. 
- The tubes were then reheated again to 100 ºC for 5 min and set in a slope 
mode so the culture medium solidifies sideway in the tubes. 
- Finally the tubes were inoculated with the fungus samples and labelled with 
code and date. 
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- For each fungus 4-6 master cultures were prepared. The master cultures are 
used to sub-culture the fungi into conical flasks, which can be used to reform 
the master cultures, if required. 
 
 
Figure 79 Master cultures of different fungi 
 
 
7.1.5  Sub-culturing in conical flasks  
Each fungus was sub-cultured into four conical flasks (250 ml each) for 2-3 weeks 
before they were transferred into Thompson bottles. The conical flasks provide 
sufficient material for large scale culturing.  They also give information about the 
growth pattern of the fungi. The content of each conical flask can be used to 
inoculate 7-10 Thompson bottles of (1 L or 2 L) capacity. 
 
Figure 80 Sub-culture in conical flask 
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7.1.6 Thompson bottles  
Thompson bottles (1 L or 2 L) were used to culture the fungi for large-scale work 
as follows: 
The mycelium of the fungus in the conical flask was crushed into small 
pieces using a sterilised spatula. 
- A small sample of material from the conical flask was transferred into each 
Thompson bottle, which contained sterilised culture medium. 
- Each set of Thompson bottles was labelled with the fungus code and 
culturing date and kept on sloped shelves especially constructed for this 
purpose. 
- The Thompson bottles were observed for 8 weeks and any contaminated 
bottle was discarded. The culture room was kept dark at 25-27 ºC. The 
culturing process can be repeated several times as required using the master 
culture Figure 81, shows the steps in the culturing process. 
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 Petri dish 
 
Agar slope 
  
 
Thompson bottle 
 
Conical flask 
Figure 81 Culturing process steps 
7.2 Extraction process 
After 8 weeks the contents of the Thompson bottles were combined and the mycelia 
were separated by filtration through a muslin cloth.  The mycelia were air-dried. The 
medium was extracted in batches of 2.5 L using ethyl acetate (3 x 700 ml) in a 
separating funnel (5 L).  Each time the separating funnel was shaken gently for a few 
minutes and then left to settle until two distinct layers formed. The upper layer (ethyl 
acetate extract) was separated and then dried over anhydrous sodium sulphate for 30 
min. The ethyl acetate was then removed in vacuo using a rotary evaporator. Finally 
the crude yield of the metabolites was determined. 
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Extraction of the culture medium  Crude extract 
 
Dried mycelium 
Figure 82 Extraction process of the culture medium 
7.3 Chromatography process 
Merck Kieselgel 60, GPF254 silica gel was used for TLC and PTLC. 
TLC plates (20 cm x 20 cm) were prepared by mixing (200 g) of the silica gel with 
(480 ml) distilled water in a round-bottomed flask (2 L). The mixture was swirled to 
make a homogenous suspension and left to stand for 1h. The suspension was spread 
on a clean glass plate and left to air-dry for 24 h at room temperature.  
PTLC plates (20 cm x 80 cm) were prepared by mixing Merck Kieselgel 60, GPF254 
silica gel (100 g) with (270 ml) distilled water in a beaker (1 L) and left to settle 45 
min before spreading on a clean glass plate. The plate was left to air-dry for 24 h at 
room temperature. Merck Kieselgel 60, 0.063-0.200 mm pore diameter was used for 
column chromatography; unless otherwise stated.  The size of the columns and the 
solvent systems used in each case were specified in context. 
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7.4 Spray reagents 
- Diazotised p-nitroaniline spray reagent was prepared as follows: 
A few drops of 5% sodium nitrite solution (described below) were added to 10%  
p-nitroaniline solution (50 ml) until the yellow colour of the solution 
disappeared.  Then sufficient quantity of 10% aqueous sodium carbonate solution 
was added until the yellow colour of the solution appeared again. 
(The 5% solution of p-nitroaniline was prepared by dissolving 7.0 g of p-
nitroaniline crystals in concentrated hydrochloric acid (90 ml) and then diluted to 
1 L. 
- Anisaldehyde spray reagent was prepared as follows: 
4-Methoxybenzaldehyde (1.0 ml) and concentrated sulphuric acid (1.0 ml) were 
added to glacial acetic acid (98.0 ml). 
7.5 Crystallisation 
The solvent conditions used for crystallisation of each pure compound, with single or 
mixture of solvents, is specified in each instance. 
7.6 Physical properties 
- Melting points were measured using a Kofler hot-stage apparatus and are 
uncorrected. 
- IR spectra were obtained using a Perkin-Elmer spectrum 100 ATR-IR 
Spectrometer. 
- ESI Mass spectra were determined using a Micromass ZMD (Single Quad) or a 
Micromass Quattro Ultima (Triple Quad). 
- Optical rotations were measured using a Perkin Elmer 141 Polarimeter equipped 
with a cell of path length 1.0 dm. 
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- 1H and 13C and 2D NMR spectra were obtained on a JEOL ECA 600 NMR 
Spectrometer. 
- Carbon atom types were determined by employing a combination of 13C NMR 
broad-band proton-decoupled spectra, and Distortionless Enhancement by 
Polarisation Transfer (DEPT) experiments. 
- Precise assignments were established by employing a combination of 1D and 2D 
NMR experiments. 
- 1H-1H correlations by double quantum-filtered COSY.  
- 1H-13C 1JCH correlations by HMQC pulse sequence. 
- 1H-13C nJCH correlations by HMBC pulse sequence. 
7.7 Secondary metabolites from fungus B127R culture medium 
Five endophytic fungi B231b, B127R, A116, B115 and B338 were collected in 
Southern Thailand from palm tree leaves Borassodendron machadonis and classified 
as Xylaria endophytes were static sub-cultured on an aqueous solution of malt extract 
into 10 conical flasks (250 ml) two for each fungus for 2 weeks.  Fungus B231b and 
B127R grew with a broad white mycelium, whereas fungus A116 produced black 
cylindrical shaped-stromata with a black base on a white mycelium.  Fungus B115 
developed brown fruiting bodies after 10 days, which were visible on a white 
mycelium, whilst fungus B338 produced a black mycelium Figure 83.  Each 
endophyte was then transferred into Thompson bottles (10 x 2 L) and allowed to 
grow on a malt extract-glucose mixture for 8 weeks.  Master cultures of these 
endophytes were made for future reference.  The matured cultures were harvested 
and the mycelia were recovered by filtration through a muslin cloth.  The respective 
aqueous filtrates were extracted into batches of (2.5 L) with ethyl acetate (3 x 700 
ml) in a separating funnel (5 L). The combined extracts were dried over anhydrous 
                      Chapter 7 
124 
 
sodium sulphate.  After removal of the ethyl acetate in vacuo gummy mixtures were 
obtained. The yields of crude products are summarised in Table 21.   
A116 gave yellowish crystals (0.58 g), which were triturated with acetone and 
recrystallised from methanol to give white hairy needles (12 mg) of cytochalasin D.  
TLC studies of the individual crude extract indicated that the four endophytes 
(B127R, B338, B231b and B115) produced the same components.  
   
Fungus B231b Fungus B127R Fungus A116 
  
           Fungus B115          Fungus B338 
Figure 83 Endophytic fungi growing in conical flasks after 10 days 
Table 21 Summary of endophytes crude extracts 
Fungus Crude Yield Description 
B127R 10.1 g Brown gum 
B231b 6.2 g Brown gum 
B338 4.6 g Gummy brown liquid 
B115 2.7 g Brown gum 
A116 0.58 g Yellowish crystals 
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7.7.1 Isolation of Cytochalasin D  
The crude extract of B127R (10.1 g) was taken up into ethyl acetate (20 ml) 
producing a thick creamy solution.  The solution was left to set aside for 24 h.  A fine 
white solid (106 mg) precipitated from solution. The solid was filtered off and 
recrystallised from  methanol to give cytochalasin D as colourless needles (79 mg), 
mp 230-232 °C, ES [M+H]
+
 m/z 508 (consistent with C30H37NO6),  [α]  -12.5º (c 1, 
dioxane), Rf  0.24 in solvent system;  toluene,  ethyl acetate and acetic acid (50:49:1),  
IRATR νmaxcm
-1
  3419, 1741 and 1692, [lit
25
., mp 267-270 °C],  δH  (C5D5N)  0.76  
(3H, d,  J  6.7 Hz, 11-CH3), 0.97 (3H, d, J  6.5 Hz, 22-CH3), 1.49 (3H, s, 23-CH3), 
1.90-1.93 (1H, m, 15-Ha), 2.41 (3H, s, 25-CH3), 2.42 (1H, s, 4-H), 2.58-2.63 (1H, m, 
15-Hb), 2.66-2.70 (1H, m, 16-H), 2.80-2.83 (2H, m, 10-H),  3.00 (1H, s, 5-H), 3.35-
3.39 (1H, m, 8-H), 3.54 (1H, s, 3-H), 4.40 (1H, d, J  10.3 Hz, 7-H), 4.98 (1H, s, 7-
OH), 5.04 (1H, s, 12-Ha), 5.40 (1H, s, 12-Hb), 5.54-5.59 (1H, m, 19-H), 5.60-5.61 
(1H, m, 13-H), 6.18 (1H, s,  21-H), 6.30-6.35 (1H, m, 14-H), 6.83 (1H, dd, J  2.5, 
13.3 Hz, 20-H), 7.20-7.35 (5H, m, aromatic protons),  9.08 (1H, s, N-H),  δc (C5D5N) 
13.59 (CH3, C-11), 19.34 (CH3, C-22), 20.51 (CH3, C-23), 24.60 (CH3, C-25), 33.13 
(CH, C-5), 38.54 (CH2, C-15), 42.43 (CH, C-16), 45.49 (CH2, C-10), 47.86 (CH, C-
8), 50.07 (CH, C-4), 53.98 (C, C-9), 54.35 (CH, C-3), 71.26 (CH, C-7), 77.98 (CH, 
C-21), 78.38 (C, C-18), 112.16 (=CH2, C-12), 126.79 (HC=C, C-4’), 127.82 (HC=C, 
C-13), 128.79 (HC=C x 2, C-3’ & C-5’), 129.89 (HC=C x 2, C-2’ & C-6’), 132.18 
(HC=C, C-19), 133.81 (HC=C, C-20), 132.75 (HC=C, C-14), 138.43 (C, C-1’), 
151.61 (C, C-6), 170.45 (C, C-24), 175.09 (C, C-1), 210.86 (C, C-17). 
7.7.2 Isolation of Coriloxin  
After the isolation of cytochalasin D, the remaining filtrate was concentrated in 
vacuo  to yield a brownish gummy liquid (5.0 g), which was triturated with acetone 
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and set aside overnight.  This afforded dark brown crystals which were recrystallised 
twice from toluene to yield optically active colourless needles of coriloxin (103 mg), 
mp 153-155 °C, ES [M+H]
+
  m/z  171 (consistent with C8H10O4), [α]   -98.4º(c 1, in 
EtOH), [lit
36
., mp 153-155 °C, [α]   -100º (c 0.33, in EtOH)], Rf  0.13 in solvent 
system; toluene, ethyl acetate and acetic acid (50:49:1),  IRATR νmaxcm
-1 
 3403, 1648 
and 1607 cm
-1, δH  (CDCl3)  1.62 (3H, s, 7-CH3), 2.68 (1H, d,  J  6.2 Hz, 4-OH), 3.30 
(1H, d,  J  1.7 Hz, 6-H),  3.73 (3H, s, 8-CH3), 4.46 (1H, d,  J  6.2  Hz, 4-H), 5.23 (1H, 
d,  J  1.7 Hz, 2-H),  δc  (CDCl3)  19.02 (CH3, C-7), 56.69 (CH3, C-8), 59.55  (C, C-5), 
60.65 (CH, C-6), 69.21 (CH, C-4), 98.29 (CH, C-2), 171.54 (C, C-3), 193.56 (C=O, 
C-1). The compound showed no phenolic properties with diazotised p- nitroaniline 
spray reagent; however it gave a yellowish green colouration after spraying with 
anisaldehyde spray reagent and heating 2-3 min at 110 ºC. 
7.7.3 Isolation of S-Mellein  
After removal of coriloxin, the crude product had a dry weight of   (3.3 g).  Two 
portions   (1 g each) of this brownish viscous liquid were chromatographed on two 
large thick layer plates (20 x 80 cm); (1.0 g) on each plate.  The plates were 
developed in a tank containing toluene, ethyl acetate and acetic acid (500:490:10).  
As the plates developed, they were removed and air-dried and then strips (1.0 cm) at 
the edges were sprayed with diazotised p-nitroaniline spray reagent to detect the 
bands.  (Band 1), (Rf 0.91) in solvent system toluene, ethyl acetate and acetic acid 
(50:49:1) was scraped off  and  washed with ethyl acetate which was removed in 
vacuo to yield a yellow oil, which was triturated with n-hexane to give a powdery 
solid (7.5 mg). This was recrystallised from n-hexane to yield S-mellein as colourless 
plates (3 mg), mp 52-53 °C, ES [M+H]
+
  m/z 179 (consistent with C10H10O3),  [α]   
+87º (c 1, in CHCl3), [lit
91
.,  mp 56-58 °C, [α]   +88º (c 0.27, in CHCl3)], IRATR νmax 
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cm
-1 
 3187,  1662, δH  (CDCl3) 1.51 (3H, d,  J 6.3 Hz, 11-CH3), 2.91 (2H, d,  J  7.0 
Hz, 4-CH2), 4.70-4.73 (1H, m, 3-H),  6.67 (1H, d,  J  7.3 Hz, 7-H), 6.87 (1H, d, J  8.4 
Hz, 5-H), 7.39 (1H, t, J  7.5 Hz, 6-H), 11.02 (1H, s, OH), δc  (CDCl3)  20.88 (CH3, C-
11),  34.73 (CH2, C-4), 76.21 (O-CH, C-3), 116.36 (C=CH, C-7),118.00 (C=CH, C-
5), 136.25 (C=CH, C-6), 108.41 (C, C-9), 139.50 (C, C-10), 162.31 (C, C-8), 170.07 
(C, C-1). 
7.7.4 Isolation of cis-4-Hydroxymellein  
The next UV active band on the preparative TLC plate at Rf 0.71 developed in 
solvent system; toluene, ethyl acetate and acetic acid (50:49:1) was removed and 
washed with ethyl acetate to yield a yellow solution. The solvent was removed in 
vacuo to afford yellowish needles, which were recrystallised from toluene to yield 
cis-4-hydroxymellein as fine colourless prisms (87 mg), mp 112-117 °C, ES [M+H]
+  
m/z 195 (consistent with C10H10O4), [α]  +48º, (c 1, in MeOH), [lit
96
.,  mp 118-119 
°C, [α]  +37.4º (c 0.33, in MeOH)], IRATR  νmax cm
-1 
 3430, 3178,  2997, 1642 and 
1615,  δH  (CDCl3)  1.57 (3H, d,  J  6.6 Hz,11-CH3),  2.04 (1H, d,  J  6.4 Hz, 4-OH), 
4.68 (1H, dd, J  6.1, 1.8 Hz, 4-H), 4.69 (1H, qd , J  6.6, 2.0 Hz, 3-H), 6.90 (1H, d,  J  
7.3 Hz, 5-H), 7.01 (1H, dd,  J  8.4, 0.9 Hz, 7-H), 7.50 (1H, t,  J   7.3 Hz,6-H), 10.98 
(1H, s, OH),  δc  (CDCl3)  16.15 (CH3, C-11), 67.39 (CH, C-4), 78.27  (CH, C-3), 
106.94 (C, C-9), 118.39 (C=CH, C-7), 118.71 (C=CH, C-5), 136.92 (C=CH, C-6), 
140.58 (C, C-10), 162.25 (C, C-8), 169.26 (C, C-1). 
7.8 Isolation of Cytochalasin D from fungus B127R mycelium 
The air-dried mycelium was pulverised (53.9 g) and soxhlet extracted with 
chloroform (400 ml) for 16 h to give a brownish gum (7.6 g).  The gum was 
dissolved in warm ethyl acetate (15 ml) and set aside for 24 h.  A white solid (2.3 g) 
was obtained after the solution was filtered off.  TLC studies showed an opaque spot 
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with diazotised p-nitroaniline spray reagent, which indicated a cytochalasin. The 
1
H 
and 
13
C NMR spectra (C5D5N) indicated that the compound was cytochalasin D, 
which was isolated and characterised from the culture medium of fungus B127R. 
7.9 Secondary metabolites from the fungus X.B315 on malt extract medium 
The fungus X.B315 was static sub-cultured on aqueous malt extract medium into five 
conical flasks (250 ml) for 14 days.  It produced a white mycelium with a black 
colouration underside; no fruiting bodies were observed Figure 84. 
  
A-in a conical flask after 2 weeks B-in Thompson bottle after 4 weeks  
Figure 84 Fungus X.B315 on malt extract-glucose mixture 
The fungus was then transferred into Thompson bottles (15 x 1L) each bottle 
containing about (500 ml) of the medium solution.  The mature fungus produced a 
white gelatine-like mycelium with black underside. 
The matured cultures were harvested and the mycelia were recovered from the brown 
culture medium by filtration through a muslin cloth and left to air-dry.  The brownish 
filtrate was extracted with ethyl acetate (700 ml) three times in a separating funnel. 
The combined extracts were dried over anhydrous sodium sulphate.  Evaporation of 
the solvent in vacuo yielded a malt crude extract (5.2 g). 
The latter was screened using TLC for its content.  The solvent system; toluene, ethyl 
acetate and acetic acid (50:49:1) used as eluent. The resultant plates showed that the 
crude extract was a mixture of three components; two spots (Rf 0.92 & 0.64) 
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developed an intense yellow colouration with diazotised p-nitroaniline spray reagent, 
whilst the third spot at Rf 0.32 developed a yellowish brown colouration.  The spot at 
Rf 0.32 showed an intense yellow colouration with acetic acid, anisaldehyde and 
sulphuric acid (98:1:1) spray reagent, which turned to red after heating 2-3 min at 
110 ºC.  
7.9.1 Isolation of Cytochalasin D from fungus X.B315  
The crude extract (5.2 g) was triturated with ethyl acetate and left overnight.  A white 
precipitate was obtained.  The white solid was filtered off and recrystallised from 
methanol to yield cytochalasin D as colourless needles (65 mg), mp 238-240 °C, ES 
[M+H]
+
 m/z 508.  This compound showed an opaque spot when treated with 
diazotised p-nitroaniline spray reagent at Rf 0.27 on TLC.  The 
1
H NMR spectrum 
(C5D5N) showed a characteristic N-H signal at δH  9.01. The spectral and physical 
data of this compound confirmed this compound as cytochalasin D the prior 
identification of which is described in Chapter 2. 
7.9.2 Isolation of R-Mellein from fungus X.B315 
After removal of cytochalasin D, the ethyl acetate crude extract (3.7 g) was 
chromatographed on four PTLC plates (20 cm x 80 cm); (1 g) on each plate. Each 
plate was prepared by mixing Merck Kieselgel GPF254 silica gel (100 g) with 
distilled water (270 ml) in a beaker (1 L) and left for 45 min to settle before 
spreading on the clean glass PTLC plate.  After applying the extract on the plate, it 
was developed in a large tank containing toluene, ethyl acetate and acetic acid 
(500:450:10). After the plates developed, they were removed and air-dried and a 
band at each end of each plate (1.0 cm) was sprayed with diazotised p-nitroaniline 
spray reagent to detect the bands.  The UV active band at Rf 0.92 was recovered and 
washed with ethyl acetate to produce a yellow oil (35 mg).  Trituration of the oil with 
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n-hexane gave a white solid (12 mg), which was recrystallised twice from the same 
solvent to yield  R-mellein as colourless plates (3 mg), mp 52-53 °C, ES [M+H]
+
  m/z 
179, [α]  -100º (c 1, in  EtOH), [lit.,39 mp 56-58 °C, [α]   -80º (c 0.02,  in EtOH)],  
δH (CDCl3) 1.52 (3H, d, J 6.3 Hz, 11-CH3), 2.93  (2H, d, J  7.0 Hz, 4-CH2), 4.69-4.75 
(1H, m, 3-H), 6.67 (1H, d,  J  7.3 Hz, 7-H), 6.87 (1H, d, J  8.4 Hz, 5-H), 7.39 (1H, t,  
J  7.5 Hz, 6-H ), 11.02 (1H, s, OH),  δc  (CDCl3)  20.88 (CH3, C-11),  34.73 (CH2,  C-
4), 76.21 (O-CH, C-3), 116.36 (C=CH, C-7), 118.00 (C=CH, C-5), 136.25 (C=CH, 
C-6), 108.41 (C, C-9), 139.50 (C, C-10), 162.31 (C, C-8), 170.07 (C, C-1). 
7.9.3 Isolation of cis,trans-4-Hydroxymellein mixture from the fungus X.B315  
The next UV active band on the PTLC plate, which had Rf 0.64, developed a strong 
orange colouration with p-nitroaniline spray reagent.  It was isolated as a pale yellow 
oil and recrystallised from petroleum ether (bp 80-100 °C) as fine colourless needles 
(4 mg) and found to be a mixture of two 4-hydroxymellein stereoisomers (C10H10O4), 
mp 121-125 °C, [lit
40
., 131-132 °C], ES [M+H]
+
  m/z 195, δH  (CDCl3) 1.49 (3H, d, J  
6.2 Hz, 11-CH3), 1.56 (3H, d,  J  6.7 Hz, 11-CH3),  2.14 (1H, s, OH), 4.57 (1H, m, 3-
H), 4.60 (1H, m, 3-H), 4.55 (1H, m, 4-H), 4.56 (1H, m, 4-H), 6.90 (1H, m, 5-H), 6.91 
(1H, m, 5-H), 7.00 (1H, m, 6-H), 7.01 (1H, m, 6-H), 7.49 (1H, m, 7-H), 7.52 (1H, 
m,7-H), 10.95 (1H, s, OH), 10.98 (1H, s, OH),  δc  (CDCl3)  16.09, 18.00 (CH3, C-
11), 67.29, 69.19 (CH, C-4), 78.29, 80.05 (CH, C-3), 106.73, 106.90 (C, C-9), 
116.35, 117.87 (C=CH, C-7), 118.39, 118.60 (C=CH, C-5), 136.89, 136.97 (C=CH, 
C-6), 140.58, 141.27 (C, C-10), 162.04, 162.14 (C, C-8), 168.59 169.29 (C, C-1). 
7.9.4 Isolation of Phloroglucinol from fungus X.B315  
A compound, which gave a violet spot under visible light on the PTLC plate at Rf  
0.32, developed a yellowish brown colouration with p-nitroaniline spray reagent, 
whilst it developed an intense yellow colouration with anisaldehyde spray reagent,  
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which turned to red after heating 2-3 min at 110 °C. The band was recovered and 
washed with ethyl acetate to produce a brown powder (420 mg) after evaporation of 
the solvent in vacuo.  The powder was recrystallised twice from H2O to yield 
phloroglucinol as colourless crystals (350 mg), mp 214-216 °C, ES [M+H]
+
  m/z 127 
(consistent with C6H6O3), IRATR νmax cm
-1   
3461, 3160 and 1609, δH (acetone-d6) 5.84 
(H x 3, s), 8.08 (OH x 3, s), δC  (acetone-d6)  94.55 (CH x 3), 159.33 (=C-OH x 3). 
7.10 Isolation of Phloroglucino from fungus X.B315 mycelium  
The air-dried mycelium (65.5 g) was pulverised. The sample was packed into a 
soxhlet thimble, which was placed into a soxhlet apparatus.  It was extracted with 
chloroform (400 ml) for 16 h.  After evaporation of the solvent in vacuo, a brown 
crude extract (5.6 g) was obtained.  The extract was then analysed for its content by 
TLC.   A solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used 
as eluent.  A visible violet spot was detected on a TLC plate at Rf 0.32. The spot 
developed a yellowish brown colouration with diazotised p-nitroaniline spray 
reagent, whilst it developed a yellow colouration with anisaldehyde spray reagent, 
which turned to red after heating 2-3 min at 110 °C.  The crude extract was warmed 
with H2O (15 ml) for 10 min.  The solution was filtered off and the filtrate was left to 
cool.  Filtration gave colourless crystals of phloroglucinol (450 mg).  It appears that 
phloroglucinol is a major metabolite produced by fungus X.B315. 
7.11 Secondary metabolites from fungus X.B315 on potato extract 
Analogous procedures to those described above for the isolation of secondary 
metabolites of X.B315 grown on malt extract-glucose mixture were applied to the 
ethyl acetate crude extract of the same fungus grown on potato-yeast-extract-glucose 
mixture.  It was found that the fungus X.B315 grown on potato-yeast-extract-glucose 
mixture produced the same metabolites, but in higher yield.  The mycelium of this 
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fungus also produced phloroglucinol. The potato extract was prepared by boiling (1 
kg) white potatoes in distilled water (5 L) for 30 min. The solution was filtered off 
through a filter paper. 
7.12 Secondary metabolites from the endophytic fungus X.62 
The fungus X.62 was isolated from palm tree leaves in Thailand and classified as a 
Xylaria endophyte.  It was received in Petri dishes as shown in Figure 85. The front 
view of the Petri dish showed a white mycelium. The reverse side of the fungus was 
also white; but with a black ring round the edge of the dish.  
 
Figure 85 Fungus X.62 as received from Thailand 
The fungus was static sub-cultured into four conical flasks (250 ml) for 2 weeks.  It 
produced a white mycelium Figure 86. 
 
Figure 86  Fungus X.62 in conical flask after 2 weeks 
 
The fungus was then cultured on a malt-yeast extract-glucose mixture into Thompson 
bottles (15 x 1L) for 8 weeks.  During the first 4 weeks, it produced a white 
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mycelium with black areas underside.  The matured cultures were harvested and the 
mycelia were recovered by filtration through a muslin cloth and left to air-dry.  The 
aqueous filtrate was extracted with ethyl acetate in a separating funnel (5 L). The 
combined fractions were dried over anhydrous sodium sulphate.  After removal of 
the solvent in vacuo, a brown crude extract was obtained (1.2 g).   
TLC analysis of the crude extract was conducted in different solvent systems. The 
resultant plates showed that the solvent systems; toluene, ethyl acetate and acetic 
acid (50:49:1), chloroform and methanol (95:5) and petroleum ether (bp 60-80 °C), 
ethyl acetate and acetic acid (50:49:1) showed that the crude extract contained a 
complex mixture of different compounds with different Rf values.  When the plates 
were sprayed with p-nitroaniline spray reagent opaque spots were revealed.  
1
H NMR 
spectroscopy (C5D5N) showed that the extract contained a mixture of cytochalasins 
according to four N-H signals.  Several attempts to isolate these compounds by 
chromatographic techniques failed.   
7.12.1 Isolation of 19,20-Epoxycytochalasin C from X.62 mycelium 
The air-dried mycelium (79.3 g) was pulverised. The powdered mycelium was 
packed firmly into a soxhlet thimble, which was placed into a soxhlet apparatus. The 
sample was extracted with chloroform (400 ml) for 16 hr.  After the evaporation of 
the solvent in vacuo, a brown gummy solid was obtained (5.0 g). The extract was 
analysed for its content by TLC.  
A solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used as 
eluent.  A single spot under short wave UV (245 nm) with Rf 0.42 was detected on a 
TLC plate.  When the plate was sprayed with p-nitroaniline reagent an opaque spot 
was developed at Rf 0.42. The ethyl acetate extract was triturated with ethyl acetate 
and left overnight. A white solid was obtained. The solid was filtered off and 
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recrystallised from methanol to yield 19,20-epoxycytochalasin C as white needles 
(373 mg), mp 266-270 °C, ES [M+H]
+
  m/z  524 (consistent with C30H37NO7), [α]   -
6.4º (c 1, in CHCl3), [lit
29., [α]  -6.8º (c 0.25, in CHCl3)],  IRATR νmax cm
-1  
3423,  
1744  and 1697,  δH (C5D5N)  0.98 (3H, d, J  6.5 Hz, 22-CH3), 1.94 (1H, dd, J 
11.1,12.2 Hz, 15-Ha), 1.24 (3H, s, 12-CH3), 1.59 (3H, s, 23-CH3), 1.83 (3H, s, 11-
CH3), 2.10 (3H, s, 25-CH3), 2.16 (1H, s, 8-H),  2.60-2.63 (1H, m, 15-Hb), 2.82-2.84 
(2H, m, 10-H), 2.85-2.88 (1H, m, 16-H), 3.17 (1H, d,  J  7.3  Hz, 4-H), 3.59 (1H, t,  J  
7.2 Hz, 3-H),  3.75 (1H, s, 19-H), 4.20 (1H, s , 20-H), 4.40 (1H, s, 7-H), 4.97 (1H, s, 
OH), 5.85-5.89 (1H, m, 13-H), 6.26 (1H, s, 21-H), 6.73-6.77 (1H, m, 14-H), 7.20-
7.35 (5H, m, aromatic protons), 9.46 (1H, s, N-H), δc (C5D5N) 14.78 (CH3, C-11), 
17.06 (CH3, C-12), 19.05 (CH3, C-22), 20.38 (CH3, C-23), 22.55 (CH3, C-25), 38.35 
(CH2, C-15), 42.00 (CH, C-16), 45.28(CH2, C-10), 50.08 (CH, C-3),51.03 (CH,C-4 ), 
52.82 (CH, C-8), 54.11 (O-CH, C-19),  60.75 (C,  C-9), 61.45 (O-CH, C-20), 68.89 
(CH, C-7),  73.36 (CH, C-21), 77.16 (C, C-18),  126.58 (C, C-5), 126.81 (HC=C, C-
4’), 128.84 (HC=C x 2, C-3’ & C-5’), 129.88 (HC=C x 2, C-2’ & C-6’), 132.21 
(HC=C, C-13), 132.89 (HC=C, C-14), 133.72 (C, C-6), 138.74 (C, C-1’), 170.84 (C, 
C-24), 175.35 (C, C-1), 216.19 (C, C-17). 
7.13 Secondary metabolites from fungus Engleromyces sinensis 
The samples of this fungus, which belongs to the family Hypocreaceae, were 
collected on Snow Mountain at ca 2700 m, Lijiang, Yunnan province in China.  The 
fungus had yellowish flesh with a hard yellowish-brown exterior crust Figure 87.  
The old herbarium material was hard and horny, but became soft when soaked in 
water.  The hard crust of the fungus was cut into pieces and pulverised using a 
grinder.  The powdered sample (60.5 g) was packed firmly into a soxhlet thimble, 
which was placed into a soxhlet apparatus. The sample was extracted with four 
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different solvents (400 ml of each) for 24 h.  The hexane fraction yielded yellowish 
oil (1.4 g), whilst the chloroformic fraction yielded a light brown gum (0.5 g).  The 
ethyl acetate fraction yielded a light brown gum (43 mg) and the methanol fraction 
yielded a dark brown gum (7.1 g).   
The different extracts were then examined for their metabolite profile by TLC.  A 
solvent system of toluene, ethyl acetate and acetic acid (50:49:1) was used as eluent. 
Hexane extract showed a UV active spot with Rf 0.9, whilst chloroform extract did 
not show any UV active spots.  Ethyl acetate and methanol extracts showed matching 
patterns of a single spot under UV Lamp at Rf 0.32.  When the plates were dried, the 
both extracts were sprayed with p-nitroaniline reagent, the spot developed an opaque 
colouration, suggesting that the ethyl acetate and methanol extracts contained the 
same component.  
 
Figure 87  Fungus Engleromyces sinensis as received from China 
7.13.1 Isolation of Engleromycin acetate  
A. Ethyl acetate extract 
A white precipitate formed in the ethyl acetate extract.  The solid  (23 mg) was 
filtered off and recrystallised twice from ethyl acetate to yield engleromycin acetate  
as colourless needles (10 mg), mp 265-269 °C [lit.,
119
  mp 226-228 °C], ES [M+H]
+
  
m/z 524, (consistent with C30H37NO7),  [α]   -220° (c 1, in  CHCl3), [lit.,
30
  [α]    
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-228° (c 0.035, in CHCl3)], IRATR νmax cm
-1  
3748,  3378,  1754 and 1670,  δH  
(C5D5N)  0.58  (3H, d,  J  6.6 Hz, 11-CH3), 0.91 (3H, d, J  6.5 Hz, 22-CH3), 1.51 
(3H, s, 23-CH3), 1.91 (1H, d, J 6.5 Hz, 15-Ha), 2.07 (3H, s, 25-CH3), 2.45 (1H, s, 4-
H), 2.71-2.76 (1H, m, 15-Hb), 2.77-2.79 (1H, m, 16-H), 2.80-2.89 (2H, m, 10-H), 
3.00-3.10 (1H, m, 5-H),  3.20 (1H, s, 8-H), 3.46 (1H, s, 3-H), 3.65 (1H, d, J 2.5 Hz, 
19-H), 4.23 (1H, d, J 2.5 Hz, 20-H), 4.32 (1H, d, J 10.3 Hz, 7-H), 4.86 (1H, s, 7-
OH), 5.27 (1H, s, 12-Ha), 5.59 (1H, s, 12-Hb), 5.91-5.96 (1H, m, 13-H), 6.16 (1H, s, 
21-H), 6.49-6.56 (1H, m, 14-H), 7.20-7.35 (5H, m, aromatic protons), 9.13 (1H, s, N-
H),  δc (C5D5N)  13.36 (CH3, C-11), 18.95 (CH3, C-22), 20.36 (CH3, C-23), 22.71 
(CH3, C-25), 32.93 (CH, C-5), 38.19 (CH2, C-15), 42.46 (CH, C-16), 45.43 (CH2, C-
10), 47.33 (CH, C-8), 50.57 (CH, C-4), 53.66 (C, C-9), 53.96 (CH, C-3), 54.37 (CH, 
C-19), 60.70 (CH, C-20), 71.37 (CH, C-7), 75.11 (CH, C-21), 77.30 (C, C-18), 
112.03 (=CH2, C-12), 126.78 (HC=C, C-4’), 128.77 (HC=C x 2, C-3’& C-5’), 
129.97 (HC=C x 2, C-2’ & C-6’), 132.04 (HC=C, C-13), 132.53 (HC=C, C-14), 
138.38 (C, C-1’), 151.39 (C, C-6), 170.62 (C, C-24), 175.04 (C, C-1), 216.37 (C, C-
17). 
B. Methanol extract 
The crude extract (7.1 g) was triturated with methanol-water (50:50) and left 
overnight. A brown solid was obtained.  The brown solid (50 mg) was filtered off 
and recrystallised three times from the same solvent system to yield engleromycin 
acetate as colourless needles (7 mg). 
7.14 Secondary metabolites from fungus X. polymorpha 
The fungus X. polymorpha, which is a plant pathogen, was collected from Thailand.  
The fungus was static sub-cultured for two weeks in 5 conical flasks (250 ml) 
containing an aqueous malt extract medium. It produced a white mycelium with a 
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light brown gelatinous underside. It started fruiting after 10 days and developed light 
brown cylindrical shaped-stromata with unbranced tips Figure 88. 
 
Figure 88 Fungus X. polymorpha in a conical flask  after 10 days 
The fungus was then sub-cultured into Thompson bottles (15 x 1L), each bottle 
containing (500 ml) of a malt-yeast extract-glucose mixture for 8 weeks. The 
matured cultures were harvested and the mycelia were recovered by filtration 
through a muslin cloth. The brownish filtrate was extracted with ethyl acetate in a 
separating funnel (5 L).   The combined extracts were dried over anhydrous sodium 
sulphate.  After the evaporation of the solvent in vacuo, a brown gummy mixture was 
obtained (2.3 g). The ethyl acetate crude extract (2.3 g) was chromatographed over 
Merck Kieselgel 60, column (3 cm x 80 cm).  The column was eluted with petroleum 
ether (bp 60-80 °C), ethyl acetate and acetic acid (30:70:1) and fractions of 3.0 ml 
were collected using an automated fraction collector.  
7.14.1 Isolation of (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’methylphenyl)-2-
methoxybut-3-enoic acid 
The component recovered (tubes 20-55) was a yellow oil, which was triturated with 
ethyl acetate to yield a white solid (13 mg), which was recrystallised from the same 
solvent to yield (3E)-4-(3’-acetyl-2’,6’-dihydroxy-5’methylphenyl)-2-methoxybut-3-
enoic acid as colourless crystals (7 mg), mp 160-163 °C, ES [M+H]
+ 
m/z 281 
(consistent with C14H16O6), [lit
34
., mp 160-165°C)], Rf  0.4 in solvent system; 
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petroleum ether (60-80 °C), ethyl acetate and acetic acid (30:70:1), IRATR νmax cm
-1 
 
3300, 1774 and 1628, δH (C5D5N) 2.28 (3H, s, 9’-CH3), 2.43 (3H, s, 8’-CH3), 3.48 
(3H, s, 5-CH3), 4.79 (1H, dd, J  6.6, 1.1 Hz, 2-H), 7.49 (1H, s, 4’-H), 7.60 (1H, dd, J 
16.2, 6.6 Hz, 3-H), 7.75 (1H, dd, J 16.2, 1.1 Hz, 4-H), 14.06 (1H, s, 2’-OH), δC 
(C5D5N) 17.08 (CH3, C-9’), 26.08 (CH3, C-8’), 56.95 (CH3, C-5), 83.58 (CH, C-2), 
112.35 (C, C-1’), 113.02 (C, C-3’), 116.80 (C, C-5’), 124.07 (CH, C-4), 129.91 (CH, 
C-3), 132.35 (CH, C-4’), 162.27 (C, C-2’), 162.70 (C, C-6’), 173.63 (C, C-1), 203.37 
(C, C-7’). 
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Chapter 8  Summary 
The Xylariaceae is a well-known family for the wide biological diversity of many of 
its species and genera. It has also been found to be an impressive source of 
metabolites of which many have proved to be novel structures
27
.  The genus Xylaria 
with worldwide distribution in tropical and sub-tropical areas has proved to be one of 
the most rewarding with 30 new compounds isolated from 30 species
27
. 
Endophytic Xylaria are an important source of novel compounds
125
 and bioactive 
agents, which can lead to the discovery of new drugs for the pharmaceutical and 
agricultural industries
47
. 
In this project the samples were collected from Xylariaceous as well as endophytic 
fungi and the fungi were static sub-cultured on different culture media.  
  In this study, secondary metabolites from five endophytic Xylaria species were 
collected from the Trad Province in Southern Thailand. The structures of the 
compounds have been elucidated by chemical and spectroscopic methods. 
The endophytic fungi B127R, B338, B115, B231b produced cytochalasin D, 
coriloxin, S-mellein and (3R,4R)-4-hydroxymellein Figure 89, suggesting that the 
four fungi were the same species, whist fungus A116 produced cytochalasin D. 
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Cytochalasin D S-Mellein Coriloxin 4-Hydroxymellein 
Figure 89 Secondary metabolites isolated from endophytic fungi 
The fungus  X.B315 was cultured on two different media; malt extract and potato-
yeast extract mixture and found to produce; cytochalasin D, R-mellein, a mixture of 
two isomers of the 4-hydroxymellein and phloroglucinol  Figure 90 . 
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Cytochalasin D R-Mellein 4-Hydroxymellein Phloroglucinol 
Figure 90 Secondary metabolites isolated from fungus X.B315 
The fungus X.62, a Xylaria endophyte, produced 19,20-epoxycytochalasin C Figure 
91. 
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Figure 91 Secondary metabolite from fungus X.62 
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Fungus Engleromyces sinensis , the second species in the genus after Engleromyces 
goetzei, produced 19,20-epoxycytochalasin D, also known as engleromycin acetate 
Figure 92. 
HN
O
OAc
CH2
O
H3C
OH
HH
CH3
OHH3C
O
 
Engleromycin acetate 
Figure 92 Secondary metabolite from fungus Engleromyces sinensis 
The fungus X. polymorpha, a plant pathogen, most likely produced globoscin
34
, 
which slowly rearranged in pyridine and to give (3E)-4-(3’-acetyl-2’,6’-dihydroxy-
5’-methylphenyl)-2-methoxybut-3-enoic acid Figure 93. 
OH
OH
H3C
O
CH3
OCH3
O
OH  
(3E)-4-(3’-Acetyl-2’,6’-dihydroxy-5’-methylphenyl)-2-
methoxybut-3-enoic acid 
Figure 93   Pyridine rearrangement product 
 
During the course of the work of fungus X. polymorpha, a second metabolite of 
unknown structure was isolated in insufficient quantities to allow full 
characterisation.  One future area of work the fungus X. polymorpha would be 
recultured on a large scale to isolate and identify this second component. Initial 
spectroscopic data suggested it could be a novel structure.  
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